<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated Sat, 05 Sep 2026 22:49:00 +0200 by Actavia system -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
		<url>
			<loc>/artkey/inf-990000-0100_About-the-journal.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.3</priority>
		</url>
		<url>
			<loc>/artkey/inf-990000-0200_O-casopisu.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.3</priority>
		</url>
		<url>
			<loc>/artkey/inf-990000-0500_for-authors.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.3</priority>
		</url>
		<url>
			<loc>/artkey/inf-990000-0600_pre-autorov.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.3</priority>
		</url>
		<url>
			<loc>/artkey/inf-990000-1300_Editorial-board.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.3</priority>
		</url>
		<url>
			<loc>/artkey/inf-990000-1400_redakcna-rada.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.3</priority>
		</url>
		<url>
			<loc>/artkey/inf-990000-1500_Supplementum.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.3</priority>
		</url>
		<url>
			<loc>/artkey/inf-990000-1600_Odporucania.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.3</priority>
		</url>
		<url>
			<loc>/current_issue.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/archive.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2026/mn1.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2026/mn1.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202601-0001_semaglutide-in-treatment-of-obesity-and-its-cardiovascular-benefits-evidence-from-clinical-studies-and-guideli.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202601-0001_semaglutide-in-treatment-of-obesity-and-its-cardiovascular-benefits-evidence-from-clinical-studies-and-guideli.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202601-0002_long-covid-and-the-pathophysiological-mechanisms-of-cardiovascular-damage.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202601-0002_long-covid-and-the-pathophysiological-mechanisms-of-cardiovascular-damage.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202601-0003_trivalvular-infective-endocarditis-a-rare-presentation-in-an-intravenous-drug-user.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202601-0003_trivalvular-infective-endocarditis-a-rare-presentation-in-an-intravenous-drug-user.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202601-0004_early-risk-stratification-of-the-patients-with-non-st-elevation-acute-coronary-syndromes-results-of-the-slovak.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202601-0004_early-risk-stratification-of-the-patients-with-non-st-elevation-acute-coronary-syndromes-results-of-the-slovak.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202601-0005_ai-that-can-save-time-and-reduce-errors.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202601-0005_ai-that-can-save-time-and-reduce-errors.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202601-0006_guidelines-af-2024-a-specifika-slovenska.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202601-0006_guidelines-af-2024-a-specifika-slovenska.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2026/mn2.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2026/mn2.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202602-0003_right-ventricular-free-wall-longitudinal-strain-in-heart-failure-with-preserved-and-mild-reduced-ejection-fract.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202602-0003_right-ventricular-free-wall-longitudinal-strain-in-heart-failure-with-preserved-and-mild-reduced-ejection-fract.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202602-0004_what-a-cardiologist-should-know-about-the-need-for-thrombophilia-screening-the-latest-recommendations.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202602-0004_what-a-cardiologist-should-know-about-the-need-for-thrombophilia-screening-the-latest-recommendations.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202602-0005_current-approach-to-cardiogenic-shock-management.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202602-0005_current-approach-to-cardiogenic-shock-management.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202602-0006_acute-perimyocarditis-as-the-initial-manifestation-of-adult-onset-still-s-disease.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202602-0006_acute-perimyocarditis-as-the-initial-manifestation-of-adult-onset-still-s-disease.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202602-0001_komentar-k-odporucaniam-esc-pre-manazment-kardiovaskularnych-ochoreni-v-gravidite-2025.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202602-0001_komentar-k-odporucaniam-esc-pre-manazment-kardiovaskularnych-ochoreni-v-gravidite-2025.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202602-0002_medziodborove-stanovisko-k-bezpecnosti-peroralnej-gestagenovej-antikoncepcie-u-zien-s-pritomnostou-rizikovych-f.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202602-0002_medziodborove-stanovisko-k-bezpecnosti-peroralnej-gestagenovej-antikoncepcie-u-zien-s-pritomnostou-rizikovych-f.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2026/mn3.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2026/mn3.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202603-0002_infective-endocarditis-the-16-year-experience-of-one-centre.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202603-0002_infective-endocarditis-the-16-year-experience-of-one-centre.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202603-0003_corrected-qt-interval-assessment-artificial-intelligence-versus-physician.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202603-0003_corrected-qt-interval-assessment-artificial-intelligence-versus-physician.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202603-0004_prevalence-and-symptom-characteristics-of-postural-orthostatic-tachycardia-syndrome-pots-in-patients-with-ort.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202603-0004_prevalence-and-symptom-characteristics-of-postural-orthostatic-tachycardia-syndrome-pots-in-patients-with-ort.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202603-0005_acute-propafenone-toxicity.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202603-0005_acute-propafenone-toxicity.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202603-0001_komentar-k-odporucaniam-esc-eacts-pre-manazment-chlopnovych-ochoreni-z-roku-2025-co-je-nove-oproti-odporucaniam.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202603-0001_komentar-k-odporucaniam-esc-eacts-pre-manazment-chlopnovych-ochoreni-z-roku-2025-co-je-nove-oproti-odporucaniam.php</loc>
			<changefreq>daily</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2025/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2025/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202501-0002_navigating-risks-and-rewards-in-percutaneous-transcatheter-mitral-commissurotomy-a-multicenter-hemodynamic-ana.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202501-0002_navigating-risks-and-rewards-in-percutaneous-transcatheter-mitral-commissurotomy-a-multicenter-hemodynamic-ana.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202501-0003_current-role-of-drug-coated-balloons-in-interventional-cardiology.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202501-0003_current-role-of-drug-coated-balloons-in-interventional-cardiology.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202501-0004_caval-filter-indications-extractions-and-complications.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202501-0004_caval-filter-indications-extractions-and-complications.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202501-0005_restrictive-cardiomyopathy-an-overview-according-to-the-latest-guidelines.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202501-0005_restrictive-cardiomyopathy-an-overview-according-to-the-latest-guidelines.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202501-0006_rare-cause-of-severe-mitral-regurgitation-or-lead.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202501-0006_rare-cause-of-severe-mitral-regurgitation-or-lead.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202501-0001_prihovor-prezidenta-slovenskej-kardiologickej-spolocnosti.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202501-0001_prihovor-prezidenta-slovenskej-kardiologickej-spolocnosti.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2025/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2025/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202502-0002_risk-profile-of-anatomical-and-functional-parameters-of-patent-foramen-ovale-and-associated-anatomical-structur.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202502-0002_risk-profile-of-anatomical-and-functional-parameters-of-patent-foramen-ovale-and-associated-anatomical-structur.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202502-0003_the-parameters-of-atrial-deformation-and-their-use-in-heart-failure-diagnostics.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202502-0003_the-parameters-of-atrial-deformation-and-their-use-in-heart-failure-diagnostics.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202502-0004_mechanical-prosthetic-valve-thrombosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202502-0004_mechanical-prosthetic-valve-thrombosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202502-0005_optical-coherence-tomography-guided-percutaneous-coronary-intervention.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202502-0005_optical-coherence-tomography-guided-percutaneous-coronary-intervention.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202502-0001_commentary-on-the-2024-esc-guidelines-for-the-management-of-elevated-blood-pressure-and-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202502-0001_commentary-on-the-2024-esc-guidelines-for-the-management-of-elevated-blood-pressure-and-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202502-0007_14-stretnutie-zastupcov-centier-pre-plucnu-arteriovu-hypertenziu-okruhly-st-l-pah.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202502-0007_14-stretnutie-zastupcov-centier-pre-plucnu-arteriovu-hypertenziu-okruhly-st-l-pah.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202502-0006_hemorrhagic-pericardial-effusion-after-removal-of-pericardial-drain-in-penetrating-atherosclerotic-ulcer-of-the.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202502-0006_hemorrhagic-pericardial-effusion-after-removal-of-pericardial-drain-in-penetrating-atherosclerotic-ulcer-of-the.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2025/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2025/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202503-0002_exposome-and-cardiovascular-diseases-the-impact-of-environmental-pollutants-on-cardiovascular-health.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202503-0002_exposome-and-cardiovascular-diseases-the-impact-of-environmental-pollutants-on-cardiovascular-health.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202503-0003_introduction-to-ffr-ct-heartflow.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202503-0003_introduction-to-ffr-ct-heartflow.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202503-0004_bromocriptine-in-the-management-of-peripartum-cardiomyopathy-a-review-of-current-evidence.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202503-0004_bromocriptine-in-the-management-of-peripartum-cardiomyopathy-a-review-of-current-evidence.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202503-0006_thrombosis-of-the-annuloplasty-ring-of-the-mitral-valve-the-cause-of-repeated-systemic-embolizations.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202503-0006_thrombosis-of-the-annuloplasty-ring-of-the-mitral-valve-the-cause-of-repeated-systemic-embolizations.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202503-0007_acute-myocarditis-in-patient-with-igg4-related-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202503-0007_acute-myocarditis-in-patient-with-igg4-related-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202503-0001_comment-on-esc-2024-guidelines-for-the-management-of-chronic-coronary-syndromes.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202503-0001_comment-on-esc-2024-guidelines-for-the-management-of-chronic-coronary-syndromes.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202503-0008_navigating-the-unknown-a-unique-pacemaker-implantation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202503-0008_navigating-the-unknown-a-unique-pacemaker-implantation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202503-0009_late-icd-lead-amputation-as-a-cause-of-recurrent-inappropriate-shocks.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202503-0009_late-icd-lead-amputation-as-a-cause-of-recurrent-inappropriate-shocks.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202503-0005_do-patients-receive-the-recommended-pharmacotherapy-after-an-acute-myocardial-infarction.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202503-0005_do-patients-receive-the-recommended-pharmacotherapy-after-an-acute-myocardial-infarction.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2025/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2025/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202504-0002_innovative-hypolipidemic-therapy-in-the-secondary-prevention-of-cardiovascular-diseases-the-experience-of-one.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202504-0002_innovative-hypolipidemic-therapy-in-the-secondary-prevention-of-cardiovascular-diseases-the-experience-of-one.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202504-0003_dressler-s-syndrome-a-literature-review.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202504-0003_dressler-s-syndrome-a-literature-review.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202504-0004_the-role-of-lipoprotein-a-in-the-pathogenesis-of-cardiovascular-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202504-0004_the-role-of-lipoprotein-a-in-the-pathogenesis-of-cardiovascular-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202504-0005_anticoagulant-therapy-in-a-patient-with-thrombocytopenia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202504-0005_anticoagulant-therapy-in-a-patient-with-thrombocytopenia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202504-0006_sinus-tachycardia-and-its-differential-diagnosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202504-0006_sinus-tachycardia-and-its-differential-diagnosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202504-0001_comment-on-esc-2024-guidelines-for-the-management-of-peripheral-arterial-and-aortic-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202504-0001_comment-on-esc-2024-guidelines-for-the-management-of-peripheral-arterial-and-aortic-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2025/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2025/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202505-0001_aldosterone-synthase-inhibitors-in-the-treatment-of-arterial-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202505-0001_aldosterone-synthase-inhibitors-in-the-treatment-of-arterial-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202505-0002_endothelial-dysfunction-as-a-key-pathomechanism-of-long-covid-a-potential-therapeutic-target.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202505-0002_endothelial-dysfunction-as-a-key-pathomechanism-of-long-covid-a-potential-therapeutic-target.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202505-0003_atypical-presentation-of-infective-endocarditis-complicated-by-dietary-induced-warfarin-resistance.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202505-0003_atypical-presentation-of-infective-endocarditis-complicated-by-dietary-induced-warfarin-resistance.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202505-0005_intimal-cardiac-sarcoma-diagnosis-as-an-unusual-cause-of-anterior-myocardial-infarction.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202505-0005_intimal-cardiac-sarcoma-diagnosis-as-an-unusual-cause-of-anterior-myocardial-infarction.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202505-0004_pivotal-clinical-trials-shaping-contemporary-cardiology-practice-news-from-the-european-society-of-cardiology.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202505-0004_pivotal-clinical-trials-shaping-contemporary-cardiology-practice-news-from-the-european-society-of-cardiology.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2024/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2024/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202401-0002_comparison-of-three-methods-for-ldl-cholesterol-calculation-for-cardiovascular-disease-risk-categorisation-in-t.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202401-0002_comparison-of-three-methods-for-ldl-cholesterol-calculation-for-cardiovascular-disease-risk-categorisation-in-t.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202401-0003_intensified-outpatient-management-post-acute-coronary-syndrome-impaks-description-of-the-project.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202401-0003_intensified-outpatient-management-post-acute-coronary-syndrome-impaks-description-of-the-project.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202401-0004_efficiency-evaluation-of-the-management-of-patients-with-arterial-hypertension-results-of-home-blood-pressure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202401-0004_efficiency-evaluation-of-the-management-of-patients-with-arterial-hypertension-results-of-home-blood-pressure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202401-0001_comment-on-2022-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202401-0001_comment-on-2022-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202401-0005_late-gadolinium-enhancement-pattern-in-gamma-sarcoglycanopathy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202401-0005_late-gadolinium-enhancement-pattern-in-gamma-sarcoglycanopathy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202401-0006_postpartum-inverted-takotsubo-syndrome.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202401-0006_postpartum-inverted-takotsubo-syndrome.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202401-0007_pulmonary-hypertension-in-patients-with-advanced-heart-failure-with-reduced-ejection-fracion-impact-of-the-new.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202401-0007_pulmonary-hypertension-in-patients-with-advanced-heart-failure-with-reduced-ejection-fracion-impact-of-the-new.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2024/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2024/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202402-0002_cardiac-dysfunction-in-septic-conditions-insights-from-echocardiographic-evaluation-and-mortality-associations.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202402-0002_cardiac-dysfunction-in-septic-conditions-insights-from-echocardiographic-evaluation-and-mortality-associations.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202402-0003_pulmonary-embolism-with-high-risk-of-early-mortality-and-endovascular-treatment.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202402-0003_pulmonary-embolism-with-high-risk-of-early-mortality-and-endovascular-treatment.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202402-0004_dobutamine-stress-echocardiography-for-assessment-of-myocardial-viability-impact-of-beta-blockade-on-exam-accu.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202402-0004_dobutamine-stress-echocardiography-for-assessment-of-myocardial-viability-impact-of-beta-blockade-on-exam-accu.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202402-0005_genetic-predisposition-to-atrial-fibrillation-in-patients-with-cardiomyopathy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202402-0005_genetic-predisposition-to-atrial-fibrillation-in-patients-with-cardiomyopathy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202402-0006_acute-ebv-myocarditis-multidimensional-imaging.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202402-0006_acute-ebv-myocarditis-multidimensional-imaging.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202402-0001_the-first-heart-suture-in-the-world-and-the-first-in-slovakia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202402-0001_the-first-heart-suture-in-the-world-and-the-first-in-slovakia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202402-0007_a-biological-role-and-potential-clinical-value-of-receptor-interacting-protein-kinase-3-in-diagnosis-of-heart.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202402-0007_a-biological-role-and-potential-clinical-value-of-receptor-interacting-protein-kinase-3-in-diagnosis-of-heart.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2024/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2024/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202403-0002_peri-implantation-and-early-post-implantation-complications-of-cardiac-implantable-electronic-devices-cieds-r.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202403-0002_peri-implantation-and-early-post-implantation-complications-of-cardiac-implantable-electronic-devices-cieds-r.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202403-0003_hypertrophic-cardiomyopathy-in-a-tertiary-care-centre-a-descriptive-analysis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202403-0003_hypertrophic-cardiomyopathy-in-a-tertiary-care-centre-a-descriptive-analysis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202403-0004_postprandial-hypotension-a-possible-cardiovascular-risk-factor.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202403-0004_postprandial-hypotension-a-possible-cardiovascular-risk-factor.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202403-0005_a-nearly-misdiagnosed-wide-complex-tachycardia-all-algorithms-have-flaws.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202403-0005_a-nearly-misdiagnosed-wide-complex-tachycardia-all-algorithms-have-flaws.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202403-0006_surprising-coronarography-finding-in-heart-transplant-patient.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202403-0006_surprising-coronarography-finding-in-heart-transplant-patient.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202403-0001_comment-on-2023-esc-guidelines-for-the-management-of-cardiovascular-diseases-in-patients-with-diabetes-from-the.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202403-0001_comment-on-2023-esc-guidelines-for-the-management-of-cardiovascular-diseases-in-patients-with-diabetes-from-the.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202403-0007_pulmonary-artery-dilatation-due-to-pressure-or-volume-overload-in-congenital-heart-diseas.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202403-0007_pulmonary-artery-dilatation-due-to-pressure-or-volume-overload-in-congenital-heart-diseas.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2024/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2024/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202404-0002_cardiological-problems-during-physical-exertion.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202404-0002_cardiological-problems-during-physical-exertion.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202404-0003_current-treatment-options-for-acute-pulmonary-embolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202404-0003_current-treatment-options-for-acute-pulmonary-embolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202404-0004_cognitive-impairment-and-atrial-fibrillation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202404-0004_cognitive-impairment-and-atrial-fibrillation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202404-0005_hypolipidemic-therapy-in-the-secondary-prevention-of-cardiovascular-events-with-regard-to-european-guidelines-a.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202404-0005_hypolipidemic-therapy-in-the-secondary-prevention-of-cardiovascular-events-with-regard-to-european-guidelines-a.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202404-0001_comments-on-the-2023-esc-guidelines-for-the-management-of-cardiomyopathies.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202404-0001_comments-on-the-2023-esc-guidelines-for-the-management-of-cardiomyopathies.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202404-0006_right-ventricular-systolic-function-predicts-survival-in-patients-with-cardiac-amyloidosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202404-0006_right-ventricular-systolic-function-predicts-survival-in-patients-with-cardiac-amyloidosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202404-0007_sticky-platelet-syndrome-as-a-cause-of-acute-myocardial-infarction-in-a-young-soccer-player.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202404-0007_sticky-platelet-syndrome-as-a-cause-of-acute-myocardial-infarction-in-a-young-soccer-player.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2024/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2024/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202405-0002_management-of-patients-with-heart-failure-experience-from-a-single-centre.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202405-0002_management-of-patients-with-heart-failure-experience-from-a-single-centre.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202405-0003_unveiling-the-hidden-threat-how-to-diagnose-pulmonary-arterial-hypertension-in-time.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202405-0003_unveiling-the-hidden-threat-how-to-diagnose-pulmonary-arterial-hypertension-in-time.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202405-0004_cardiotoxic-treatment-in-oncohaematology.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202405-0004_cardiotoxic-treatment-in-oncohaematology.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202405-0005_invasive-hemodynamic-monitoring.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202405-0005_invasive-hemodynamic-monitoring.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202405-0006_zilebesiran-a-new-principle-and-new-hope-in-the-treatment-of-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202405-0006_zilebesiran-a-new-principle-and-new-hope-in-the-treatment-of-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202405-0001_comment-on-2023-esc-guidelines-for-the-management-of-acute-coronary-syndromes.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202405-0001_comment-on-2023-esc-guidelines-for-the-management-of-acute-coronary-syndromes.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2024/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2024/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202406-0002_left-ventricular-global-longitudinal-strain-in-the-evaluation-of-left-ventricular-heart-failure-and-ischaemic-h.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202406-0002_left-ventricular-global-longitudinal-strain-in-the-evaluation-of-left-ventricular-heart-failure-and-ischaemic-h.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202406-0003_glucagon-like-peptide-1-receptor-agonists-a-new-pharmacological-treatment-for-chronic-heart-failure-with-prese.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202406-0003_glucagon-like-peptide-1-receptor-agonists-a-new-pharmacological-treatment-for-chronic-heart-failure-with-prese.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202406-0004_rare-case-presentation-of-thoracic-aortic-aneurysm-and-aortic-dissection-in-adolescent.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202406-0004_rare-case-presentation-of-thoracic-aortic-aneurysm-and-aortic-dissection-in-adolescent.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202406-0001_comment-on-2023-esc-guidelines-for-the-management-of-endocarditis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202406-0001_comment-on-2023-esc-guidelines-for-the-management-of-endocarditis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202406-0005_progressive-cachexia-as-a-main-symptom-of-hypereosinophilic-syndrome.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202406-0005_progressive-cachexia-as-a-main-symptom-of-hypereosinophilic-syndrome.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2023/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2023/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202301-0001_patients-x2bc-characteristics-in-acute-aortic-dissection-debakey-type-i-single-center-study.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202301-0001_patients-x2bc-characteristics-in-acute-aortic-dissection-debakey-type-i-single-center-study.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202301-0002_the-use-of-fixed-dose-combinations-of-antihypertensive-drugs-in-slovakia-in-2019-2021.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202301-0002_the-use-of-fixed-dose-combinations-of-antihypertensive-drugs-in-slovakia-in-2019-2021.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202301-0003_drug-therapy-in-chronic-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202301-0003_drug-therapy-in-chronic-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202301-0004_dilated-cardiomyopathy-current-opinions-on-classification-diagnosis-and-treatment.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202301-0004_dilated-cardiomyopathy-current-opinions-on-classification-diagnosis-and-treatment.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202301-0005_european-esc-esh-versus-american-acc-aha-guidelines-on-the-management-of-arterial-hypertension-parallels-and-d.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202301-0005_european-esc-esh-versus-american-acc-aha-guidelines-on-the-management-of-arterial-hypertension-parallels-and-d.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202301-0006_masked-hypertension-diagnosis-treatment-and-prognosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202301-0006_masked-hypertension-diagnosis-treatment-and-prognosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202301-0007_traumatic-coronary-artery-dissection-in-sports-use-of-ffrct-and-literature-review.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202301-0007_traumatic-coronary-artery-dissection-in-sports-use-of-ffrct-and-literature-review.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202301-0008_ultrasound-guided-thrombolysis-of-a-pulmonary-embolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202301-0008_ultrasound-guided-thrombolysis-of-a-pulmonary-embolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2023/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2023/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202302-0002_hypertension-in-pregnancy-how-to-manage-patients-according-to-the-latest-recommendations.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202302-0002_hypertension-in-pregnancy-how-to-manage-patients-according-to-the-latest-recommendations.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202302-0003_lyme-carditis-one-face-of-lyme-borreliosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202302-0003_lyme-carditis-one-face-of-lyme-borreliosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202302-0004_heart-failure-screening-and-prevention-in-type-2-diabetes-mellitus.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202302-0004_heart-failure-screening-and-prevention-in-type-2-diabetes-mellitus.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202302-0005_complications-in-patients-with-fontan-circulation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202302-0005_complications-in-patients-with-fontan-circulation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202302-0006_fbi-tachycardia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202302-0006_fbi-tachycardia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202302-0001_comment-on-2022-esc-guidelines-on-cardio-oncology.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202302-0001_comment-on-2022-esc-guidelines-on-cardio-oncology.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202302-0008_12-stretnutie-zastupcov-centier-pre-plucnu-arteriovu-hypertenziu.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202302-0008_12-stretnutie-zastupcov-centier-pre-plucnu-arteriovu-hypertenziu.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202302-0007_prediction-of-left-ventricular-reverse-remodelling-mini-review-on-clinical-aspects.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202302-0007_prediction-of-left-ventricular-reverse-remodelling-mini-review-on-clinical-aspects.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2023/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2023/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202303-0002_correlation-of-the-pde4d-rs2910829-polymorphism-genotypes-with-selected-cardiovascular-health-indicators-in-the.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202303-0002_correlation-of-the-pde4d-rs2910829-polymorphism-genotypes-with-selected-cardiovascular-health-indicators-in-the.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202303-0003_25-years-of-heart-transplantation-in-children-in-slovakia-retrospective-analysis-of-group.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202303-0003_25-years-of-heart-transplantation-in-children-in-slovakia-retrospective-analysis-of-group.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202303-0004_is-left-ventricular-ejection-fraction-still-a-limiting-factor-in-the-treatment-of-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202303-0004_is-left-ventricular-ejection-fraction-still-a-limiting-factor-in-the-treatment-of-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202303-0005_cardiac-implantable-electronic-devices-in-the-slovak-republic-data-from-slovimpuls-register.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202303-0005_cardiac-implantable-electronic-devices-in-the-slovak-republic-data-from-slovimpuls-register.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202303-0006_arrhythmic-mitral-valve-prolapse.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202303-0006_arrhythmic-mitral-valve-prolapse.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202303-0007_stress-cardiomyopathy-in-young-woman-after-cesarean-section-with-sars-cov-2-inf.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202303-0007_stress-cardiomyopathy-in-young-woman-after-cesarean-section-with-sars-cov-2-inf.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202303-0001_2022-esc-guidelines-on-cardiovascular-assessment-and-management-of-patients-undergoing-non-cardiac-surgery.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202303-0001_2022-esc-guidelines-on-cardiovascular-assessment-and-management-of-patients-undergoing-non-cardiac-surgery.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202303-0008_paravalvular-leak-treatment-with-a-transapical-valve-in-valve-implantation-of-a-sapien-3-ultra-valve-after-tran.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202303-0008_paravalvular-leak-treatment-with-a-transapical-valve-in-valve-implantation-of-a-sapien-3-ultra-valve-after-tran.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2023/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2023/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202304-0002_survival-and-causes-of-death-in-patients-after-heart-transplantation-in-the-slovak-republic.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202304-0002_survival-and-causes-of-death-in-patients-after-heart-transplantation-in-the-slovak-republic.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202304-0003_coenzyme-q10-in-targeted-supportive-therapy-of-heart-failure-a-comprehensive-review-and-proposal-of-an-algori.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202304-0003_coenzyme-q10-in-targeted-supportive-therapy-of-heart-failure-a-comprehensive-review-and-proposal-of-an-algori.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202304-0004_direct-oral-anticoagulants-in-the-treatment-of-left-ventricular-thrombosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202304-0004_direct-oral-anticoagulants-in-the-treatment-of-left-ventricular-thrombosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202304-0005_the-role-of-calcium-calmodulin-dependent-protein-kinase-2-in-serious-cardiovascular-pathologies-and-its-clinica.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202304-0005_the-role-of-calcium-calmodulin-dependent-protein-kinase-2-in-serious-cardiovascular-pathologies-and-its-clinica.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202304-0006_chronic-cardiorenal-syndrome.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202304-0006_chronic-cardiorenal-syndrome.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202304-0001_comment-on-2021-esc-guidelines-on-cardiovascular-disease-prevention-in-clinical-practice.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202304-0001_comment-on-2021-esc-guidelines-on-cardiovascular-disease-prevention-in-clinical-practice.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2023/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2023/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202305-0001_the-significance-of-laboratory-parameters-in-predicting-short-term-mortality-in-patients-with-acute-pulmonary-e.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202305-0001_the-significance-of-laboratory-parameters-in-predicting-short-term-mortality-in-patients-with-acute-pulmonary-e.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202305-0002_coronary-microvascular-dysfunction-and-vasoprovocative-test-examination-in-clinical-practice.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202305-0002_coronary-microvascular-dysfunction-and-vasoprovocative-test-examination-in-clinical-practice.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202305-0003_perspectives-of-anticoagulation-therapy-in-cardiovascular-medicine.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202305-0003_perspectives-of-anticoagulation-therapy-in-cardiovascular-medicine.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202305-0004_current-view-arterial-calcifications.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202305-0004_current-view-arterial-calcifications.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202305-0005_takotsubo-cardiomyopathy-after-pacemaker-implantation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202305-0005_takotsubo-cardiomyopathy-after-pacemaker-implantation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202305-0006_two-congenital-anomalies-an-alternative-access-persistent-left-superior-vena-cava.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202305-0006_two-congenital-anomalies-an-alternative-access-persistent-left-superior-vena-cava.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202305-0007_ebstein-s-anomaly-of-the-tricuspid-valve-management-the-importance-of-right-ventricle-assessment.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202305-0007_ebstein-s-anomaly-of-the-tricuspid-valve-management-the-importance-of-right-ventricle-assessment.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2023/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2023/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202306-0001_the-role-of-vasoactive-hormones-in-pathogenesis-of-vasovagal-syncope.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202306-0001_the-role-of-vasoactive-hormones-in-pathogenesis-of-vasovagal-syncope.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202306-0002_atrial-high-rate-episodes-in-clinical-practice.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202306-0002_atrial-high-rate-episodes-in-clinical-practice.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202306-0003_cardiac-tamponade-as-the-first-manifestation-of-cardiac-angiosarcoma.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202306-0003_cardiac-tamponade-as-the-first-manifestation-of-cardiac-angiosarcoma.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202306-0004_ankle-blood-pressure-valid-alternative-of-brachial-blood-pressure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202306-0004_ankle-blood-pressure-valid-alternative-of-brachial-blood-pressure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202306-0005_ct-coronary-angiography-and-ct-myocardial-perfusion.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202306-0005_ct-coronary-angiography-and-ct-myocardial-perfusion.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2022/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2022/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202201-0002_current-treatment-trends-of-the-non-st-segment-elevation-acute-coronary-syndrome-in-the-slovak-republic-analys.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202201-0002_current-treatment-trends-of-the-non-st-segment-elevation-acute-coronary-syndrome-in-the-slovak-republic-analys.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202201-0003_ventriculo-ventricular-interaction-in-severe-aortal-stenosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202201-0003_ventriculo-ventricular-interaction-in-severe-aortal-stenosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202201-0004_vericiguat-new-drug-in-heart-failure-treatment-and-possibilities-of-its-clinical-use.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202201-0004_vericiguat-new-drug-in-heart-failure-treatment-and-possibilities-of-its-clinical-use.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202201-0005_proteomic-markers-associated-with-the-progression-of-atherosclerosis-in-type-2-diabetes.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202201-0005_proteomic-markers-associated-with-the-progression-of-atherosclerosis-in-type-2-diabetes.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202201-0006_transcatheter-left-atrial-appendage-closure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202201-0006_transcatheter-left-atrial-appendage-closure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202201-0007_transthyretin-cardiac-amyloidosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202201-0007_transthyretin-cardiac-amyloidosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202201-0001_prihovor-prezidentky-slovenskej-kardiologickej-spolocnosti.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202201-0001_prihovor-prezidentky-slovenskej-kardiologickej-spolocnosti.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2022/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2022/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202202-0002_cardiovascular-risk-clusters-in-2-813-hospitalised-seniors.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202202-0002_cardiovascular-risk-clusters-in-2-813-hospitalised-seniors.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202202-0003_combination-treatment-a-tool-to-improve-the-prognosis-of-patients-with-pulmonary-arterial-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202202-0003_combination-treatment-a-tool-to-improve-the-prognosis-of-patients-with-pulmonary-arterial-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202202-0004_what-is-new-in-patients-with-hfpef.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202202-0004_what-is-new-in-patients-with-hfpef.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202202-0005_indications-for-speckle-tracking-echocardiography-in-routine-practice.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202202-0005_indications-for-speckle-tracking-echocardiography-in-routine-practice.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202202-0006_diagnostics-of-the-substrate-of-myocardial-damage-after-overcoming-minoca-and-its-clinical-significance.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202202-0006_diagnostics-of-the-substrate-of-myocardial-damage-after-overcoming-minoca-and-its-clinical-significance.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202202-0001_comment-on-2021-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202202-0001_comment-on-2021-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202202-0007_sudden-cardiac-death-in-athletes-and-its-prevention-in-slovakia-a-public-health-issue.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202202-0007_sudden-cardiac-death-in-athletes-and-its-prevention-in-slovakia-a-public-health-issue.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202202-0008_vybrane-abstrakty-xxxvii-kongresu-slovenskej-hypertenziologickej-spolocnosti-slovenskej-lekarskej-spolocnosti.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202202-0008_vybrane-abstrakty-xxxvii-kongresu-slovenskej-hypertenziologickej-spolocnosti-slovenskej-lekarskej-spolocnosti.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2022/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2022/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202203-0004_the-relationship-between-cardiac-resynchronization-therapy-and-serum-levels-of-copeptin.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202203-0004_the-relationship-between-cardiac-resynchronization-therapy-and-serum-levels-of-copeptin.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202203-0005_three-dimensional-transesophageal-echocardiography-in-transcatheter-aortic-valve-implantation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202203-0005_three-dimensional-transesophageal-echocardiography-in-transcatheter-aortic-valve-implantation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202203-0006_pulmonary-embolism-and-covid-19.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202203-0006_pulmonary-embolism-and-covid-19.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202203-0002_cardiac-pacing-in-the-treatment-of-vasovagal-syncope-new-technologies-and-old-questions.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202203-0002_cardiac-pacing-in-the-treatment-of-vasovagal-syncope-new-technologies-and-old-questions.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202203-0003_significance-of-ct-coronary-angiography-in-diagnosis-and-management-of-coronary-artery-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202203-0003_significance-of-ct-coronary-angiography-in-diagnosis-and-management-of-coronary-artery-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202203-0001_comment-on-2021-esc-guidelines-on-cardiac-pacing-and-cardiac-resynchronization-therapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202203-0001_comment-on-2021-esc-guidelines-on-cardiac-pacing-and-cardiac-resynchronization-therapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202203-0007_za-profesorom-mudr-igorom-riecanskym-drsc.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202203-0007_za-profesorom-mudr-igorom-riecanskym-drsc.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2022/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2022/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202204-0001_comparison-of-right-ventricular-function-in-patients-undergoing-transcatheter-aortic-valve-implantation-and-sur.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202204-0001_comparison-of-right-ventricular-function-in-patients-undergoing-transcatheter-aortic-valve-implantation-and-sur.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202204-0002_the-role-of-thromboelastometry-in-monitoring-the-response-to-antiplatelet-therapy-our-experiences-and-review-o.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202204-0002_the-role-of-thromboelastometry-in-monitoring-the-response-to-antiplatelet-therapy-our-experiences-and-review-o.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202204-0003_perspectives-of-mitochondrial-cardiology.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202204-0003_perspectives-of-mitochondrial-cardiology.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202204-0004_right-heart-catheterization-methodology-indications-focus-on-patients-in-cardiogenic-shock.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202204-0004_right-heart-catheterization-methodology-indications-focus-on-patients-in-cardiogenic-shock.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202204-0005_minoca-myocardial-infarction-without-coronary-artery-obstruction-case-report-and-review-of-literature.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202204-0005_minoca-myocardial-infarction-without-coronary-artery-obstruction-case-report-and-review-of-literature.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2022/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2022/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202205-0002_time-trends-in-cardiac-stress-testing-and-imaging-in-slovakia-during-the-years-2011-2021-part-i.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202205-0002_time-trends-in-cardiac-stress-testing-and-imaging-in-slovakia-during-the-years-2011-2021-part-i.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202205-0003_determining-optimal-threshold-for-lumen-stenosis-in-coronary-ct-angiography-to-select-patients-for-heart-cathet.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202205-0003_determining-optimal-threshold-for-lumen-stenosis-in-coronary-ct-angiography-to-select-patients-for-heart-cathet.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202205-0004_predictors-of-knowledge-of-blood-pressure-a-descriptive-study.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202205-0004_predictors-of-knowledge-of-blood-pressure-a-descriptive-study.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202205-0005_primary-hyperaldosteronism-an-often-underestimated-reason-for-arterial-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202205-0005_primary-hyperaldosteronism-an-often-underestimated-reason-for-arterial-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202205-0006_the-role-of-renal-denervation-in-the-treatment-of-resistant-arterial-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202205-0006_the-role-of-renal-denervation-in-the-treatment-of-resistant-arterial-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202205-0007_preventing-and-treating-anthracycline-cardiotoxicity.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202205-0007_preventing-and-treating-anthracycline-cardiotoxicity.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202205-0008_cardiac-resynchronization-therapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202205-0008_cardiac-resynchronization-therapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202205-0009_coronary-artery-aneurysm-after-kawasaki-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202205-0009_coronary-artery-aneurysm-after-kawasaki-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202205-0001_comment-on-2021-esc-eacts-guidelines-on-the-management-of-valvular-heart-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202205-0001_comment-on-2021-esc-eacts-guidelines-on-the-management-of-valvular-heart-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2021/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2021/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202101-0007_incidence-and-severity-of-erectile-dysfunction-in-patients-with-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202101-0007_incidence-and-severity-of-erectile-dysfunction-in-patients-with-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202101-0008_interaction-of-perivascular-adipose-tissue-and-h2s-in-mesenteric-artery-in-experiment.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202101-0008_interaction-of-perivascular-adipose-tissue-and-h2s-in-mesenteric-artery-in-experiment.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202101-0003_venous-thromboembolism-in-pregnancy-what-the-latest-real-world-data-say.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202101-0003_venous-thromboembolism-in-pregnancy-what-the-latest-real-world-data-say.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202101-0004_arterial-hypertension-and-cognitive-functions-in-seniors.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202101-0004_arterial-hypertension-and-cognitive-functions-in-seniors.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202101-0005_dual-inhibition-of-neprilysin-and-angiotensin-ii-type-1-receptor-in-light-of-clinical-studies.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202101-0005_dual-inhibition-of-neprilysin-and-angiotensin-ii-type-1-receptor-in-light-of-clinical-studies.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202101-0006_the-use-of-deformation-parameters-in-assessment-of-left-ventricle-subclinical-dysfunction.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202101-0006_the-use-of-deformation-parameters-in-assessment-of-left-ventricle-subclinical-dysfunction.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202101-0009_transcatheter-mitral-valve-replacement-with-tendyne-valve-the-first-two-cases-in-slovakia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202101-0009_transcatheter-mitral-valve-replacement-with-tendyne-valve-the-first-two-cases-in-slovakia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202101-0010_eosinophil-a-good-servant-but-a-bad-master.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202101-0010_eosinophil-a-good-servant-but-a-bad-master.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202101-0001_komentar-k-odporucaniam-esc-pre-manazment-pacientov-so-supraventrikularnymi-tachykardiami-z-roku-2019.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202101-0001_komentar-k-odporucaniam-esc-pre-manazment-pacientov-so-supraventrikularnymi-tachykardiami-z-roku-2019.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202101-0002_preco-dnes-na-slovensku-excesivne-zomierame-pre-sars-cov-2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202101-0002_preco-dnes-na-slovensku-excesivne-zomierame-pre-sars-cov-2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202101-0011_10-virtualne-stretnutie-zastupcov-centier-pre-plucnu-arteriovu-hypertenziu.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202101-0011_10-virtualne-stretnutie-zastupcov-centier-pre-plucnu-arteriovu-hypertenziu.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202101-0012_deskripcia-praxe-ambulantnych-kardiologov.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202101-0012_deskripcia-praxe-ambulantnych-kardiologov.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2021/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2021/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202102-0002_case-fatality-rate-among-elderly-patients-with-acute-coronary-syndrome-and-its-temporal-changes-during-the-earl.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202102-0002_case-fatality-rate-among-elderly-patients-with-acute-coronary-syndrome-and-its-temporal-changes-during-the-earl.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202102-0003_spironolactone-and-its-use-in-the-treatment-of-arterial-hypertension-in-real-world-practice-in-the-slovak-repub.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202102-0003_spironolactone-and-its-use-in-the-treatment-of-arterial-hypertension-in-real-world-practice-in-the-slovak-repub.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202102-0004_the-effect-of-age-and-hypertension-on-activity-of-circulating-matrix-metalloproteinases-mmp-2-and-mmp-9-in-ra.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202102-0004_the-effect-of-age-and-hypertension-on-activity-of-circulating-matrix-metalloproteinases-mmp-2-and-mmp-9-in-ra.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202102-0005_prothrombotic-milieu-arterial-and-venous-thrombosis-in-covid-19-disease-and-its-clinical-impact.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202102-0005_prothrombotic-milieu-arterial-and-venous-thrombosis-in-covid-19-disease-and-its-clinical-impact.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202102-0006_the-value-of-transthoracic-echocardiography-in-patients-with-left-ventricular-assist-devices.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202102-0006_the-value-of-transthoracic-echocardiography-in-patients-with-left-ventricular-assist-devices.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202102-0001_komentar-k-novym-odporucaniam-esc-pre-manazment-pacientov-s-akutnym-infarktom-myokardu-bez-pretrvavajucich-elev.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202102-0001_komentar-k-novym-odporucaniam-esc-pre-manazment-pacientov-s-akutnym-infarktom-myokardu-bez-pretrvavajucich-elev.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2021/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2021/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202103-0002_screening-for-arterial-hypertension-in-primary-healthcare-facilities-in-slovakia-the-charter-70-2023-initia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202103-0002_screening-for-arterial-hypertension-in-primary-healthcare-facilities-in-slovakia-the-charter-70-2023-initia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202103-0007_adult-cardiac-surgery-report-2020-the-first-annual-report-from-the-slovak-cardiac-surgery-registry-national.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202103-0007_adult-cardiac-surgery-report-2020-the-first-annual-report-from-the-slovak-cardiac-surgery-registry-national.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202103-0003_necroptosis-mediated-damage-of-atrial-myocardium-another-proarrhythmic-factor-of-atrial-fibrillation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202103-0003_necroptosis-mediated-damage-of-atrial-myocardium-another-proarrhythmic-factor-of-atrial-fibrillation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202103-0004_covid-19-vaccination-and-thrombosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202103-0004_covid-19-vaccination-and-thrombosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202103-0005_biomarkers-in-heart-failure-from-well-established-to-promising.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202103-0005_biomarkers-in-heart-failure-from-well-established-to-promising.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202103-0006_antiallergic-premedication-for-hypersensitive-patients-before-radiographic-examinations-with-administration-of.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202103-0006_antiallergic-premedication-for-hypersensitive-patients-before-radiographic-examinations-with-administration-of.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202103-0008_from-hfpef-and-atrial-fibrillation-to-severe-functional-mitral-regurgitation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202103-0008_from-hfpef-and-atrial-fibrillation-to-severe-functional-mitral-regurgitation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202103-0009_current-focus-on-the-quantification-of-aortal-stenosis-severity.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202103-0009_current-focus-on-the-quantification-of-aortal-stenosis-severity.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202103-0001_comment-on-2020-esc-guidelines-for-the-diagnosis-and-management-of-atrial-fibrillation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202103-0001_comment-on-2020-esc-guidelines-for-the-diagnosis-and-management-of-atrial-fibrillation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2021/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2021/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202105-0003_management-of-myocardial-infarction-in-slovakia-in-the-period-of-the-2020-covid-19-pandemic-current-analysis-o.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202105-0003_management-of-myocardial-infarction-in-slovakia-in-the-period-of-the-2020-covid-19-pandemic-current-analysis-o.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202105-0004_covid-19-in-patients-with-pulmonary-arterial-hypertension-analysis-after-the-second-pandemic-wave-in-slovakia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202105-0004_covid-19-in-patients-with-pulmonary-arterial-hypertension-analysis-after-the-second-pandemic-wave-in-slovakia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202105-0005_left-atrial-coupling-index-the-new-predictor-of-outcome-in-severe-aortic-stenosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202105-0005_left-atrial-coupling-index-the-new-predictor-of-outcome-in-severe-aortic-stenosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202105-0006_stimulation-of-soluble-guanylate-cyclase-a-novel-treatment-target-in-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202105-0006_stimulation-of-soluble-guanylate-cyclase-a-novel-treatment-target-in-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202105-0007_cardio-renal-benefit-of-glp-1-receptor-agonists.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202105-0007_cardio-renal-benefit-of-glp-1-receptor-agonists.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202105-0008_perspectives-of-microrna-as-potential-biomarkers-in-the-diagnostic-puzzle-of-pulmonary-arterial-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202105-0008_perspectives-of-microrna-as-potential-biomarkers-in-the-diagnostic-puzzle-of-pulmonary-arterial-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202105-0001_comments-on-2020-esc-guidelines-on-sports-cardiology-and-exercise-in-patients-with-cardiovascular-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202105-0001_comments-on-2020-esc-guidelines-on-sports-cardiology-and-exercise-in-patients-with-cardiovascular-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202105-0002_comment-on-2020-esc-guidelines-for-the-management-of-adult-congenital-heart-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202105-0002_comment-on-2020-esc-guidelines-for-the-management-of-adult-congenital-heart-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202105-0009_prechodna-porucha-prietoku-outflow-kanylou-zriedkava-komplikacia-u-pacienta-s-mechanickou-podporou-lavej-komo.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202105-0009_prechodna-porucha-prietoku-outflow-kanylou-zriedkava-komplikacia-u-pacienta-s-mechanickou-podporou-lavej-komo.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2020/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2020/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202001-0006_long-term-left-ventricular-assist-devices-in-the-treatment-of-heart-failure-in-slovakia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202001-0006_long-term-left-ventricular-assist-devices-in-the-treatment-of-heart-failure-in-slovakia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202001-0001_heart-failure-and-diabetes-mellitus-dangerous-association.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202001-0001_heart-failure-and-diabetes-mellitus-dangerous-association.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202001-0002_cardiac-amyloidosis-rare-or-underdiagnosed.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202001-0002_cardiac-amyloidosis-rare-or-underdiagnosed.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202001-0003_baroreceptor-activation-therapy-new-approach-in-therapy-of-patients-with-advanced-chronic-heart-failure-and-w.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202001-0003_baroreceptor-activation-therapy-new-approach-in-therapy-of-patients-with-advanced-chronic-heart-failure-and-w.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202001-0004_secondary-mitral-regurgitation-and-chronic-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202001-0004_secondary-mitral-regurgitation-and-chronic-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202001-0005_structural-valve-deterioration.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202001-0005_structural-valve-deterioration.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202001-0007_complication-of-pulmonary-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202001-0007_complication-of-pulmonary-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202001-0008_aneurysm-of-left-ventricle-and-lvad-implantation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202001-0008_aneurysm-of-left-ventricle-and-lvad-implantation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202001-0009_rare-diseases-in-cardiology-small-volume-great-importance.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202001-0009_rare-diseases-in-cardiology-small-volume-great-importance.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2020/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2020/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202002-0005_transmural-dispersion-of-ventricular-repolarization-and-its-relation-to-incidence-of-malignant-ventricular-arrh.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202002-0005_transmural-dispersion-of-ventricular-repolarization-and-its-relation-to-incidence-of-malignant-ventricular-arrh.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202002-0006_clarify-registry-five-years-follow-up-of-patients-with-chronic-coronary-syndrome.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202002-0006_clarify-registry-five-years-follow-up-of-patients-with-chronic-coronary-syndrome.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202002-0007_polypill-in-seniors-possible-frequency-of-fixed-drug-combination-according-to-the-safis-study.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202002-0007_polypill-in-seniors-possible-frequency-of-fixed-drug-combination-according-to-the-safis-study.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202002-0008_indication-and-importance-of-abpm-in-clinical-practice.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202002-0008_indication-and-importance-of-abpm-in-clinical-practice.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202002-0009_cardiac-mitochondria-in-the-role-of-cardioprotective-strategies.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202002-0009_cardiac-mitochondria-in-the-role-of-cardioprotective-strategies.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202002-0003_manazment-emergentnych-kardiologickych-stavov-u-pacientov-so-suspektnou-alebo-potvrdenou-infekciou-covid-19.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202002-0003_manazment-emergentnych-kardiologickych-stavov-u-pacientov-so-suspektnou-alebo-potvrdenou-infekciou-covid-19.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202002-0010_effect-of-sub-chronic-administration-of-pioglitazone-on-blood-pressure-and-endothelial-function-in-borderline-h.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202002-0010_effect-of-sub-chronic-administration-of-pioglitazone-on-blood-pressure-and-endothelial-function-in-borderline-h.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202002-0001_covid-19-editorial-prezidenta-sks.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202002-0001_covid-19-editorial-prezidenta-sks.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202002-0004_2019-esc-guidelines-on-the-diagnosis-and-management-of-chronic-coronary-syndromes-comment-on-the-guidelines.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202002-0004_2019-esc-guidelines-on-the-diagnosis-and-management-of-chronic-coronary-syndromes-comment-on-the-guidelines.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202002-0002_health-care-workers-and-patient-focused-proposal-for-anti-epidemic-management-during-the-covid-19-epidemics-in.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202002-0002_health-care-workers-and-patient-focused-proposal-for-anti-epidemic-management-during-the-covid-19-epidemics-in.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202002-0011_plucna-arteriova-hypertenzia-informacia-z-vedeckeho-a-odborneho-rokovania.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202002-0011_plucna-arteriova-hypertenzia-informacia-z-vedeckeho-a-odborneho-rokovania.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2020/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2020/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202003-0004_an-evening-dose-of-antihypertensive-drugs-reduces-cardiovascular-risk-message-of-the-hygia-chronotherapy-tria.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202003-0004_an-evening-dose-of-antihypertensive-drugs-reduces-cardiovascular-risk-message-of-the-hygia-chronotherapy-tria.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202003-0005_dental-procedures-in-oral-anticoagulation-therapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202003-0005_dental-procedures-in-oral-anticoagulation-therapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202003-0006_the-effect-of-antidepressants-on-the-cardiovascular-system-and-the-safety-of-cardiovascular-drugs-in-depressive.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202003-0006_the-effect-of-antidepressants-on-the-cardiovascular-system-and-the-safety-of-cardiovascular-drugs-in-depressive.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202003-0007_left-ventricular-multipoint-pacing.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202003-0007_left-ventricular-multipoint-pacing.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202003-0008_cytokines-in-relation-to-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202003-0008_cytokines-in-relation-to-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202003-0009_animal-models-of-pulmonary-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202003-0009_animal-models-of-pulmonary-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202003-0003_the-role-of-somatic-characteristics-in-the-assessment-of-cardiometabolic-risk-in-adolescents.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202003-0003_the-role-of-somatic-characteristics-in-the-assessment-of-cardiometabolic-risk-in-adolescents.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202003-0001_comment-on-2019-esc-eas-guidelines-for-the-management-of-dyslipidaemias.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202003-0001_comment-on-2019-esc-eas-guidelines-for-the-management-of-dyslipidaemias.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202003-0002_prispevok-k-aktualnej-diskusii-o-organizacii-predoperacnych-vysetreni-pred-elektivnou-nekardialnou-chirurgiou-v.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202003-0002_prispevok-k-aktualnej-diskusii-o-organizacii-predoperacnych-vysetreni-pred-elektivnou-nekardialnou-chirurgiou-v.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2020/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2020/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202004-0004_role-of-adrenomedullin-galectin-3-and-soluble-st2-in-hypertensive-patients-at-risk-of-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202004-0004_role-of-adrenomedullin-galectin-3-and-soluble-st2-in-hypertensive-patients-at-risk-of-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202004-0005_exact-classification-of-left-ventricular-function.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202004-0005_exact-classification-of-left-ventricular-function.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202004-0006_potassium-disturbances-and-some-drugs-in-seniors-with-atrial-fibrillation-data-from-safis-study.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202004-0006_potassium-disturbances-and-some-drugs-in-seniors-with-atrial-fibrillation-data-from-safis-study.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202004-0007_is-it-important-to-reduce-serum-levels-of-lp-a-in-secondary-prevention-of-cardiovascular-morbidity-and-mortali.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202004-0007_is-it-important-to-reduce-serum-levels-of-lp-a-in-secondary-prevention-of-cardiovascular-morbidity-and-mortali.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202004-0008_effect-of-growth-hormone-hypersecretion-on-the-cardiovascular-system.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202004-0008_effect-of-growth-hormone-hypersecretion-on-the-cardiovascular-system.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202004-0003_odporucania-na-dialkove-monitorovanie-kardialnych-implantovatelnych-elektronickych-pristrojov.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202004-0003_odporucania-na-dialkove-monitorovanie-kardialnych-implantovatelnych-elektronickych-pristrojov.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202004-0010_left-atrial-thrombus-despite-continuous-oral-anticoagulant-therapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202004-0010_left-atrial-thrombus-despite-continuous-oral-anticoagulant-therapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202004-0011_supraventricular-tachycardia-in-idiopathic-pulmonary-arterial-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202004-0011_supraventricular-tachycardia-in-idiopathic-pulmonary-arterial-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202004-0009_vitamin-c-supplementation-promotes-whole-blood-rheology-in-healthy-humans.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202004-0009_vitamin-c-supplementation-promotes-whole-blood-rheology-in-healthy-humans.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202004-0001_comment-on-the-2019-esc-easd-guidelines-on-diabetes-pre-diabetes-and-cardiovascular-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202004-0001_comment-on-the-2019-esc-easd-guidelines-on-diabetes-pre-diabetes-and-cardiovascular-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202004-0002_poziadavky-na-specializovane-kardiologicke-pracovisko-opravnene-na-implantaciu-kardioverterov-defibrilatorov-i.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202004-0002_poziadavky-na-specializovane-kardiologicke-pracovisko-opravnene-na-implantaciu-kardioverterov-defibrilatorov-i.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2020/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2020/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202005-0003_management-of-patients-with-cardiac-implantable-electronic-devices-and-diagnostic-indication-for-magnetic.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202005-0003_management-of-patients-with-cardiac-implantable-electronic-devices-and-diagnostic-indication-for-magnetic.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202005-0004_gerontocardiology-covid-19.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202005-0004_gerontocardiology-covid-19.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202005-0005_the-impact-of-long-term-no-deficiency-on-the-vasoactive-properties-of-thoracic-aorta-nos-activity-and-plasma.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202005-0005_the-impact-of-long-term-no-deficiency-on-the-vasoactive-properties-of-thoracic-aorta-nos-activity-and-plasma.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202005-0006_left-atrial-appendage-occlusion-early-and-late-complications.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202005-0006_left-atrial-appendage-occlusion-early-and-late-complications.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202005-0007_ascending-aortic-aneurysm-and-treatment-with-the-pears-method.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202005-0007_ascending-aortic-aneurysm-and-treatment-with-the-pears-method.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202005-0009_ruska-pocas-pandemie-covid-19-ano-ale-ake-diabol-je-v-detailoch.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202005-0009_ruska-pocas-pandemie-covid-19-ano-ale-ake-diabol-je-v-detailoch.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202005-0001_medicine-covid-19-cardiology-and-the-year-2020.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202005-0001_medicine-covid-19-cardiology-and-the-year-2020.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202005-0002_comment-on-2019-esc-guidelines-on-the-diagnosis-and-management-of-acute-pulmonary-embolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202005-0002_comment-on-2019-esc-guidelines-on-the-diagnosis-and-management-of-acute-pulmonary-embolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-202005-0008_sprava-z-kongresu-aha-virtualny-kongres-v-usa-13-16-november-2020.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-202005-0008_sprava-z-kongresu-aha-virtualny-kongres-v-usa-13-16-november-2020.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2019/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2019/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201901-0003_managing-cardiotoxicity-induced-by-chemotherapy-in-centers-from-low-income-countries.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201901-0003_managing-cardiotoxicity-induced-by-chemotherapy-in-centers-from-low-income-countries.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201901-0004_risk-stratification-in-pulmonary-artery-hypertension-the-way-to-better-outcomes.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201901-0004_risk-stratification-in-pulmonary-artery-hypertension-the-way-to-better-outcomes.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201901-0005_how-is-the-treatment-of-diabetic-patients-changed-to-reduce-cardiovascular-risk.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201901-0005_how-is-the-treatment-of-diabetic-patients-changed-to-reduce-cardiovascular-risk.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201901-0006_bystander-cpr-and-successful-primary-percutaneous-coronary-intervention.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201901-0006_bystander-cpr-and-successful-primary-percutaneous-coronary-intervention.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201901-0001_comment-on-2017-european-society-of-cardiology-guidelines-on-the-management-of-valvular-heart-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201901-0001_comment-on-2017-european-society-of-cardiology-guidelines-on-the-management-of-valvular-heart-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201901-0002_kardiologia-v-roku-2017-chlopnove-chyby.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201901-0002_kardiologia-v-roku-2017-chlopnove-chyby.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201901-0007_s-icd-and-chest-compressions-oversensing-new-experience.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201901-0007_s-icd-and-chest-compressions-oversensing-new-experience.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201901-0008_historia-magistra-vitae-history-is-the-master-teacher-of-our-life-alexander-s-nadas-my-teacher-and-friend.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201901-0008_historia-magistra-vitae-history-is-the-master-teacher-of-our-life-alexander-s-nadas-my-teacher-and-friend.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2019/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2019/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201902-0002_management-of-the-patent-foramen-ovale-in-cryptogenic-ischemic-stroke-statement-of-the-slovak-society-of-card.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201902-0002_management-of-the-patent-foramen-ovale-in-cryptogenic-ischemic-stroke-statement-of-the-slovak-society-of-card.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201902-0003_significance-of-selected-new-biomarkers-in-diagnosis-of-abdominal-aortic-aneurysm.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201902-0003_significance-of-selected-new-biomarkers-in-diagnosis-of-abdominal-aortic-aneurysm.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201902-0005_clinical-handover-of-patients-for-specialized-centre-care-from-pre-hospital-to-in-hospital-care-a-narrative-r.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201902-0005_clinical-handover-of-patients-for-specialized-centre-care-from-pre-hospital-to-in-hospital-care-a-narrative-r.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201902-0006_delayed-onset-of-ventricular-fibrillation-after-low-voltage-electrical-injury.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201902-0006_delayed-onset-of-ventricular-fibrillation-after-low-voltage-electrical-injury.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201902-0001_o-srdci-a-jablku-nova-paradigma-ich-vztahu-v-roku-2019.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201902-0001_o-srdci-a-jablku-nova-paradigma-ich-vztahu-v-roku-2019.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201902-0007_problematika-praxe-ambulantnych-kardiologov-na-slovensku-vysledky-anonymnej-ankety.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201902-0007_problematika-praxe-ambulantnych-kardiologov-na-slovensku-vysledky-anonymnej-ankety.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201902-0004_alirocumab-reduces-total-non-fatal-and-fatal-cardiovascular-events-from-the-odyssey-outcomes-study.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201902-0004_alirocumab-reduces-total-non-fatal-and-fatal-cardiovascular-events-from-the-odyssey-outcomes-study.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201902-0008_americka-kardiologicka-spolocnost-sprava-z-kongresu-v-new-orleanse-16-19-marec-2019.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201902-0008_americka-kardiologicka-spolocnost-sprava-z-kongresu-v-new-orleanse-16-19-marec-2019.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2019/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2019/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201904-0004_patient-management-after-myocardial-infarction.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201904-0004_patient-management-after-myocardial-infarction.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201904-0005_clarify-registry-focus-on-the-subgroup-of-patients-with-stable-angina-pectoris.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201904-0005_clarify-registry-focus-on-the-subgroup-of-patients-with-stable-angina-pectoris.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201904-0006_the-potential-effect-of-lhrh-angonists-on-myocardial-angiogenesis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201904-0006_the-potential-effect-of-lhrh-angonists-on-myocardial-angiogenesis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201904-0008_proprotein-convertase-subtilisin-kexin-type-9-inhibitors-in-the-treatment-of-a-patient-with-dyslipidemia-and-m.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201904-0008_proprotein-convertase-subtilisin-kexin-type-9-inhibitors-in-the-treatment-of-a-patient-with-dyslipidemia-and-m.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201904-0003_permanent-stimulation-of-his-bundle-initial-experiences.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201904-0003_permanent-stimulation-of-his-bundle-initial-experiences.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201904-0001_stvrta-univerzalna-definicia-infarktu-myokardu-komentar-k-esc-acc-aha-whf-2018-odporucaniam.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201904-0001_stvrta-univerzalna-definicia-infarktu-myokardu-komentar-k-esc-acc-aha-whf-2018-odporucaniam.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201904-0002_esc-eacts-odporucania-pre-revaskularizaciu-myokardu-z-roku-2018-komentar-k-odporucaniam.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201904-0002_esc-eacts-odporucania-pre-revaskularizaciu-myokardu-z-roku-2018-komentar-k-odporucaniam.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201904-0007_syncardia-total-artificial-heart-as-a-bridge-to-transplant-current-results-at-the-national-institute-of-cardi.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201904-0007_syncardia-total-artificial-heart-as-a-bridge-to-transplant-current-results-at-the-national-institute-of-cardi.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2019/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2019/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201906-0003_cardiotoxicity-induced-by-immune-checkpoint-inhibitors-used-in-cancer-immunotherapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201906-0003_cardiotoxicity-induced-by-immune-checkpoint-inhibitors-used-in-cancer-immunotherapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201906-0004_importance-of-hematopoietic-stem-cells-in-the-pathogenesis-and-treatment-of-cardiovascular-diseases-the-role-o.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201906-0004_importance-of-hematopoietic-stem-cells-in-the-pathogenesis-and-treatment-of-cardiovascular-diseases-the-role-o.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201906-0005_alcohol-and-health.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201906-0005_alcohol-and-health.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201906-0006_unexpected-etiology-of-syncope.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201906-0006_unexpected-etiology-of-syncope.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201906-0007_left-ventricular-mass-myxoma-or-thrombus.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201906-0007_left-ventricular-mass-myxoma-or-thrombus.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201906-0001_comment-on-2018-esc-guidelines-for-the-management-of-cardiovascular-diseases-during-pregnancy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201906-0001_comment-on-2018-esc-guidelines-for-the-management-of-cardiovascular-diseases-during-pregnancy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201906-0002_esc-guidelines-for-the-management-of-syncope-2018-comment-on-the-guidelines.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201906-0002_esc-guidelines-for-the-management-of-syncope-2018-comment-on-the-guidelines.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201906-0008_stretnutie-zastupcov-centier-pre-plucnu-arteriovu-hypertenziu.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201906-0008_stretnutie-zastupcov-centier-pre-plucnu-arteriovu-hypertenziu.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2018/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2018/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201801-0001_epit-hf-survey-of-chronic-heart-failure-with-reduced-mid-range-and-preserved-ejection-fraction-in-slovakia-pa.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201801-0001_epit-hf-survey-of-chronic-heart-failure-with-reduced-mid-range-and-preserved-ejection-fraction-in-slovakia-pa.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201801-0002_assessment-of-left-ventricular-arrhythmogenic-substrate-in-patients-with-ischemic-heart-disease-by-cardiac-magn.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201801-0002_assessment-of-left-ventricular-arrhythmogenic-substrate-in-patients-with-ischemic-heart-disease-by-cardiac-magn.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201801-0004_antithrombotic-therapy-in-seniors-with-atrial-fibrillation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201801-0004_antithrombotic-therapy-in-seniors-with-atrial-fibrillation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201801-0005_do-we-need-a-magnet-in-the-ambulance-case-studies-from-pre-hospital-emergency-medical-service.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201801-0005_do-we-need-a-magnet-in-the-ambulance-case-studies-from-pre-hospital-emergency-medical-service.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201801-0003_benign-heart-tumors-cardiac-myxoma.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201801-0003_benign-heart-tumors-cardiac-myxoma.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2018/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2018/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201802-0004_gonadal-status-in-males-with-acute-coronary-syndrome-and-the-extent-of-coronary-artery-disease-a-comparative.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201802-0004_gonadal-status-in-males-with-acute-coronary-syndrome-and-the-extent-of-coronary-artery-disease-a-comparative.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201802-0005_ischaemic-heart-disease-which-way-can-treatment-of-hypertension-help-us-here.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201802-0005_ischaemic-heart-disease-which-way-can-treatment-of-hypertension-help-us-here.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201802-0006_first-implantation-of-the-total-artificial-heart-in-slovakia-in-patient-with-critical-biventricular-heart-fail.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201802-0006_first-implantation-of-the-total-artificial-heart-in-slovakia-in-patient-with-critical-biventricular-heart-fail.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201802-0007_early-graft-thrombosis-following-cabg-due-to-antithrombin-iii-deficiency.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201802-0007_early-graft-thrombosis-following-cabg-due-to-antithrombin-iii-deficiency.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201802-0001_to-najlepsie-z-kardiologie-v-roku-2017.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201802-0001_to-najlepsie-z-kardiologie-v-roku-2017.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201802-0002_kardiologia-v-roku-2017-arytmie-a-elektroimpulzogeneratory.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201802-0002_kardiologia-v-roku-2017-arytmie-a-elektroimpulzogeneratory.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201802-0003_odyssey-outcomes-clinical-study-implications-for-us.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201802-0003_odyssey-outcomes-clinical-study-implications-for-us.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2018/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2018/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201803-0003_potential-anxiolytic-effect-of-melatonin-on-intact-and-l-name-hypertensive-rats.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201803-0003_potential-anxiolytic-effect-of-melatonin-on-intact-and-l-name-hypertensive-rats.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201803-0001_comment-on-european-society-of-cardiology-to-actualisation-guidelines-for-dual-antiplatelet-therapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201803-0001_comment-on-european-society-of-cardiology-to-actualisation-guidelines-for-dual-antiplatelet-therapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201803-0004_betablockers-and-systolic-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201803-0004_betablockers-and-systolic-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201803-0005_artificial-intelligence-opens-new-horizons-in-science-and-medicine-and-offers-sophisticated-solutions-to-comple.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201803-0005_artificial-intelligence-opens-new-horizons-in-science-and-medicine-and-offers-sophisticated-solutions-to-comple.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201803-0002_kardiologia-v-roku-2017.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201803-0002_kardiologia-v-roku-2017.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2018/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2018/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201804-0004_compensatory-effects-of-nitric-oxide-and-hydrogen-sulfide-in-thoracic-aorta-in-conditions-of-essential-hyperten.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201804-0004_compensatory-effects-of-nitric-oxide-and-hydrogen-sulfide-in-thoracic-aorta-in-conditions-of-essential-hyperten.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201804-0001_comment-on-2017-esc-guidelines-on-the-diagnosis-and-treatment-of-peripheral-arterial-diseases-in-collaboration.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201804-0001_comment-on-2017-esc-guidelines-on-the-diagnosis-and-treatment-of-peripheral-arterial-diseases-in-collaboration.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201804-0005_heart-failure-2017.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201804-0005_heart-failure-2017.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201804-0007_pulmonary-embolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201804-0007_pulmonary-embolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201804-0008_9th-conference-of-the-international-coenzyme-q10-association-21-24-jun-2018-new-york-usa.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201804-0008_9th-conference-of-the-international-coenzyme-q10-association-21-24-jun-2018-new-york-usa.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201804-0002_kardiologia-v-roku-2017-aorta-a-periferna-cirkulacia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201804-0002_kardiologia-v-roku-2017-aorta-a-periferna-cirkulacia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201804-0006_kardiologia-v-roku-2017-srdcove-zlyhavanie.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201804-0006_kardiologia-v-roku-2017-srdcove-zlyhavanie.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201804-0003_the-year-in-cardiology-2017-aorta-and-peripheral-circulation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201804-0003_the-year-in-cardiology-2017-aorta-and-peripheral-circulation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2018/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2018/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201805-0002_idarucizumab-for-urgent-reversal-of-dabigatran-before-orthotopic-heart-transplantation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201805-0002_idarucizumab-for-urgent-reversal-of-dabigatran-before-orthotopic-heart-transplantation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201805-0004_primary-mediastinal-liposarcoma-and-perioperative-incidentalome.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201805-0004_primary-mediastinal-liposarcoma-and-perioperative-incidentalome.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201805-0005_inappropriate-shocks-from-subcutaneous-implantable-cardioverter-defibrillator-induced-by-chest-compressions.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201805-0005_inappropriate-shocks-from-subcutaneous-implantable-cardioverter-defibrillator-induced-by-chest-compressions.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201805-0006_kardiologia-2018.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201805-0006_kardiologia-2018.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201805-0001_kardiologia-v-roku-2017-koronarne-intervencie.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201805-0001_kardiologia-v-roku-2017-koronarne-intervencie.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201805-0003_do-gonadotropin-releasing-hormone-antagonists-have-a-lower-risk-of-cardiovascular-complications-in-comparison-t.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201805-0003_do-gonadotropin-releasing-hormone-antagonists-have-a-lower-risk-of-cardiovascular-complications-in-comparison-t.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2018/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2018/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201806-0002_the-role-of-novel-biomarkers-in-acute-cardiorenal-syndrome.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201806-0002_the-role-of-novel-biomarkers-in-acute-cardiorenal-syndrome.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201806-0004_matrix-metalloproteinases-and-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201806-0004_matrix-metalloproteinases-and-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201806-0005_papillary-fibroelastoma-of-the-mitral-valve-in-a-patient-with-recurrent-syncope.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201806-0005_papillary-fibroelastoma-of-the-mitral-valve-in-a-patient-with-recurrent-syncope.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201806-0001_comment-on-2018-esc-esh-guidelines-for-management-of-arterial-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201806-0001_comment-on-2018-esc-esh-guidelines-for-management-of-arterial-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201806-0003_kardiologia-v-roku-2017-zobrazovacie-metodiky.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201806-0003_kardiologia-v-roku-2017-zobrazovacie-metodiky.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2017/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2017/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201701-0003_quality-of-life-in-patients-with-atrial-fibrillation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201701-0003_quality-of-life-in-patients-with-atrial-fibrillation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201701-0004_ecg-signs-of-left-ventricular-hypertrophy-results-of-computer-simulations.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201701-0004_ecg-signs-of-left-ventricular-hypertrophy-results-of-computer-simulations.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201701-0005_dynamic-beat-to-beat-changes-of-the-cardiac-electric-field-due-to-psycho-emotional-load.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201701-0005_dynamic-beat-to-beat-changes-of-the-cardiac-electric-field-due-to-psycho-emotional-load.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201701-0006_noninvasive-identification-of-local-disorders-of-electrogenesis-in-ventricular-arrhythmias.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201701-0006_noninvasive-identification-of-local-disorders-of-electrogenesis-in-ventricular-arrhythmias.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201701-0007_pulmonary-hypertension-associated-with-systemic-sclerosis-too-many-grey-zones.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201701-0007_pulmonary-hypertension-associated-with-systemic-sclerosis-too-many-grey-zones.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201701-0008_anemia-and-endothelin-receptor-antagonists-a-real-risk.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201701-0008_anemia-and-endothelin-receptor-antagonists-a-real-risk.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201701-0001_cell-therapy-of-limbs-ischemia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201701-0001_cell-therapy-of-limbs-ischemia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201701-0002_empagliflozin-and-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201701-0002_empagliflozin-and-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2017/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2017/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201702-0002_is-there-an-adequate-indication-for-invasive-diagnosis-among-patients-with-nste-acs-analysis-of-the-slovacs-2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201702-0002_is-there-an-adequate-indication-for-invasive-diagnosis-among-patients-with-nste-acs-analysis-of-the-slovacs-2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201702-0003_the-influence-of-wine-on-cholesterol-levels-in-people-with-low-to-middle-cardiovascular-risk-in-vino-veritas.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201702-0003_the-influence-of-wine-on-cholesterol-levels-in-people-with-low-to-middle-cardiovascular-risk-in-vino-veritas.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201702-0004_syncope-unit-current-trend-in-diagnostics-and-therapy-of-syncope.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201702-0004_syncope-unit-current-trend-in-diagnostics-and-therapy-of-syncope.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201702-0005_genetics-of-peripheral-arterial-occlusive-disease-of-the-lower-extremities-pad.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201702-0005_genetics-of-peripheral-arterial-occlusive-disease-of-the-lower-extremities-pad.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201702-0001_position-paper-of-the-european-society-of-cardiology-on-antitumour-therapy-and-its-cardiovascular-toxicity.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201702-0001_position-paper-of-the-european-society-of-cardiology-on-antitumour-therapy-and-its-cardiovascular-toxicity.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2017/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2017/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201703-0001_management-of-patients-with-acute-coronary-syndromes-in-slovakia-in-2015-current-analysis-of-the-slovaks-regis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201703-0001_management-of-patients-with-acute-coronary-syndromes-in-slovakia-in-2015-current-analysis-of-the-slovaks-regis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201703-0002_the-efficacy-of-non-pharmacological-treatment-of-obesity-in-a-spa.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201703-0002_the-efficacy-of-non-pharmacological-treatment-of-obesity-in-a-spa.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201703-0003_mitochondrial-cardiology.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201703-0003_mitochondrial-cardiology.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201703-0004_what-is-a-thrombus-wedged-in-the-patent-foramen-ovale-capable-of.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201703-0004_what-is-a-thrombus-wedged-in-the-patent-foramen-ovale-capable-of.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2017/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2017/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201704-0002_prognosis-of-heart-failure-with-preserved-ejection-fraction-and-heart-failure-with-reduced-ejection-fraction-in.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201704-0002_prognosis-of-heart-failure-with-preserved-ejection-fraction-and-heart-failure-with-reduced-ejection-fraction-in.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201704-0003_registry-clarify-an-overview-of-slovak-data-after-five-years.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201704-0003_registry-clarify-an-overview-of-slovak-data-after-five-years.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201704-0001_flash-update-on-mitraclip-based-treatment-of-mitral-regurgitation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201704-0001_flash-update-on-mitraclip-based-treatment-of-mitral-regurgitation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201704-0004_prognostic-significance-of-adrenomedullin-galectin-3-and-soluble-st2-in-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201704-0004_prognostic-significance-of-adrenomedullin-galectin-3-and-soluble-st2-in-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2017/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2017/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201705-0001_demographic-and-clinical-characteristics-in-patients-hospitalised-with-heart-failure-in-slovakia-slovasez-ii-r.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201705-0001_demographic-and-clinical-characteristics-in-patients-hospitalised-with-heart-failure-in-slovakia-slovasez-ii-r.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201705-0002_mortality-of-patients-with-acute-pulmonary-embolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201705-0002_mortality-of-patients-with-acute-pulmonary-embolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201705-0003_the-mystery-of-hdl.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201705-0003_the-mystery-of-hdl.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201705-0004_prolongation-of-the-qtc-interval-induced-by-systemic-tumor-therapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201705-0004_prolongation-of-the-qtc-interval-induced-by-systemic-tumor-therapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201705-0005_preeclampsia-and-cardiovascular-diseases-the-consequence-and-cause.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201705-0005_preeclampsia-and-cardiovascular-diseases-the-consequence-and-cause.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201705-0006_microrna-information-about-myocardial-damage-or-biomarker-of-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201705-0006_microrna-information-about-myocardial-damage-or-biomarker-of-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2017/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2017/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201706-0001_epit-hf-survey-of-chronic-heart-failure-with-reduced-mid-range-and-preserved-ejection-fraction-in-slovakia-pa.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201706-0001_epit-hf-survey-of-chronic-heart-failure-with-reduced-mid-range-and-preserved-ejection-fraction-in-slovakia-pa.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201706-0003_characteristics-of-erythrocytes-and-risk-factors-for-cardiovascular-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201706-0003_characteristics-of-erythrocytes-and-risk-factors-for-cardiovascular-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201706-0002_effect-of-perivascular-adipose-tissue-on-the-reactivity-of-conduit-arteries-in-rats-with-different-predispositi.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201706-0002_effect-of-perivascular-adipose-tissue-on-the-reactivity-of-conduit-arteries-in-rats-with-different-predispositi.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201706-0004_comment-on-the-2016-esc-guidelines-for-cardiovascular-prevention.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201706-0004_comment-on-the-2016-esc-guidelines-for-cardiovascular-prevention.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2016/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2016/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201601-0002_urinary-ngal-as-a-predictor-of-acute-kidney-injury-in-patients-with-acute-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201601-0002_urinary-ngal-as-a-predictor-of-acute-kidney-injury-in-patients-with-acute-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201601-0003_the-role-of-rotation-assessed-by-3d-speckle-tracking-echocardiography-in-determination-of-origin-of-heart-failu.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201601-0003_the-role-of-rotation-assessed-by-3d-speckle-tracking-echocardiography-in-determination-of-origin-of-heart-failu.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201601-0004_novel-oral-anticoagulants-in-treatment-and-secondary-prevention-of-venous-thromboembolism-in-current-clinical-p.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201601-0004_novel-oral-anticoagulants-in-treatment-and-secondary-prevention-of-venous-thromboembolism-in-current-clinical-p.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201601-0005_the-role-of-cachexia-and-obesity-in-patients-with-chronic-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201601-0005_the-role-of-cachexia-and-obesity-in-patients-with-chronic-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201601-0006_mitralclip-intervention-therapy-of-mitral-insufficiency.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201601-0006_mitralclip-intervention-therapy-of-mitral-insufficiency.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201601-0008_water-medium-of-life.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201601-0008_water-medium-of-life.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201601-0001_cardiovascular-medicine-in-slovakia-and-slovak-society-of-cardiology-reality-trends-and-objectives.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201601-0001_cardiovascular-medicine-in-slovakia-and-slovak-society-of-cardiology-reality-trends-and-objectives.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201601-0007_empagliflozin-sodium-glucose-co-transporter-2-inhibitor-the-hope-for-type-2-diabetes-mellitus.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201601-0007_empagliflozin-sodium-glucose-co-transporter-2-inhibitor-the-hope-for-type-2-diabetes-mellitus.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2016/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2016/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201602-0002_where-is-the-place-of-serum-high-sensitivity-troponin-t-in-the-early-diagnostic-of-acute-myocardial-infarction.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201602-0002_where-is-the-place-of-serum-high-sensitivity-troponin-t-in-the-early-diagnostic-of-acute-myocardial-infarction.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201602-0003_circulating-microparticles-new-risk-factor-or-biomarker-for-cardiovascular-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201602-0003_circulating-microparticles-new-risk-factor-or-biomarker-for-cardiovascular-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201602-0004_homozygous-familial-hypercholesterolaemia-and-its-treatment.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201602-0004_homozygous-familial-hypercholesterolaemia-and-its-treatment.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201602-0005_isometric-counterpressure-manoeuvres-in-prevention-of-reflex-vasovagal-syncope.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201602-0005_isometric-counterpressure-manoeuvres-in-prevention-of-reflex-vasovagal-syncope.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201602-0008_2015-esc-guidelines-for-the-management-of-acute-coronary-syndromes-in-patients-presenting-without-persistent-st.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201602-0008_2015-esc-guidelines-for-the-management-of-acute-coronary-syndromes-in-patients-presenting-without-persistent-st.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201602-0001_radiofrequency-renal-sympathetic-denervation-in-patients-with-resistant-arterial-hypertension-12-month-follow.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201602-0001_radiofrequency-renal-sympathetic-denervation-in-patients-with-resistant-arterial-hypertension-12-month-follow.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201602-0007_comment-on-2015-esc-guidelines-for-the-management-of-acute-coronary-syndromes-in-patients-without-persistent-st.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201602-0007_comment-on-2015-esc-guidelines-for-the-management-of-acute-coronary-syndromes-in-patients-without-persistent-st.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201602-0006_iny-pohlad-na-markery-endotelovej-dysfunkcie-ako-prediktory-gestacnej-hypertenzie-a-preeklampsie.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201602-0006_iny-pohlad-na-markery-endotelovej-dysfunkcie-ako-prediktory-gestacnej-hypertenzie-a-preeklampsie.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2016/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2016/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201603-0001_the-management-of-patients-with-persistent-atrial-fibrillation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201603-0001_the-management-of-patients-with-persistent-atrial-fibrillation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201603-0002_register-of-pacemakers-and-implanted-cardioverter-defibrillators-in-the-slovak-republic.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201603-0002_register-of-pacemakers-and-implanted-cardioverter-defibrillators-in-the-slovak-republic.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201603-0003_register-of-cathether-ablation-in-the-slovak-republic.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201603-0003_register-of-cathether-ablation-in-the-slovak-republic.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201603-0004_cardiovascular-diseases-and-mirna.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201603-0004_cardiovascular-diseases-and-mirna.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201603-0006_2015-esc-guidelines-for-the-management-of-patients-with-ventricular-arrhythmias-and-the-prevention-of-sudden-ca.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201603-0006_2015-esc-guidelines-for-the-management-of-patients-with-ventricular-arrhythmias-and-the-prevention-of-sudden-ca.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201603-0005_comment-on-2015-esc-guidelines-for-the-management-of-patients-with-ventricular-arrhythmias-and-the-prevention-o.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201603-0005_comment-on-2015-esc-guidelines-for-the-management-of-patients-with-ventricular-arrhythmias-and-the-prevention-o.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2016/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2016/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201604-0002_molecular-mechanisms-of-quercetin-effects-in-rats-exposed-to-prolonged-doxorubicin-administration.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201604-0002_molecular-mechanisms-of-quercetin-effects-in-rats-exposed-to-prolonged-doxorubicin-administration.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201604-0003_the-impact-of-the-use-of-extracorporeal-circulation-on-the-early-postoperative-igg-concentrations-potential-e.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201604-0003_the-impact-of-the-use-of-extracorporeal-circulation-on-the-early-postoperative-igg-concentrations-potential-e.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201604-0004_background-and-principles-of-effective-diuretic-treatment-in-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201604-0004_background-and-principles-of-effective-diuretic-treatment-in-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201604-0005_2015-esc-guidelines-for-the-management-of-infective-endocarditis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201604-0005_2015-esc-guidelines-for-the-management-of-infective-endocarditis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201604-0001_inhibition-of-neprilysin-new-horizon-in-heart-failure-therapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201604-0001_inhibition-of-neprilysin-new-horizon-in-heart-failure-therapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2016/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2016/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201605-0001_oxidative-stress-after-pulmonary-veins-isolation-deteriorative-or-protective-factor.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201605-0001_oxidative-stress-after-pulmonary-veins-isolation-deteriorative-or-protective-factor.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201605-0002_lipid-spectrum-and-lipid-particles-size-in-patients-with-acute-coronary-syndromes-in-younger-age-groups.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201605-0002_lipid-spectrum-and-lipid-particles-size-in-patients-with-acute-coronary-syndromes-in-younger-age-groups.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201605-0003_time-delay-due-to-health-care-system-and-impact-of-the-delay-on-the-short-term-prognosis-of-patients-with-stemi.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201605-0003_time-delay-due-to-health-care-system-and-impact-of-the-delay-on-the-short-term-prognosis-of-patients-with-stemi.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201605-0007_2015-esc-guidelines-for-the-diagnosis-and-management-of-pericardial-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201605-0007_2015-esc-guidelines-for-the-diagnosis-and-management-of-pericardial-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201605-0004_anti-fibrillating-and-defibrillating-capability-of-atorvastatin-melatonin-and-omega-3-fatty-acids-demonstrated.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201605-0004_anti-fibrillating-and-defibrillating-capability-of-atorvastatin-melatonin-and-omega-3-fatty-acids-demonstrated.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201605-0005_an-approach-to-the-management-of-cardiovascular-risk-in-diabetic-patients-where-are-we-in-2016.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201605-0005_an-approach-to-the-management-of-cardiovascular-risk-in-diabetic-patients-where-are-we-in-2016.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201605-0006_acute-coronary-syndromes-need-to-the-change-traditional-antiplatelet-therapy-for-a-new-one-benefit-risk-and.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201605-0006_acute-coronary-syndromes-need-to-the-change-traditional-antiplatelet-therapy-for-a-new-one-benefit-risk-and.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2016/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2016/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201606-0001_echocardiography-and-atrial-fibrillation-in-seniors-data-from-safis-study.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201606-0001_echocardiography-and-atrial-fibrillation-in-seniors-data-from-safis-study.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201606-0004_2015-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201606-0004_2015-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201606-0003_comment-on-2015-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201606-0003_comment-on-2015-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201606-0002_activities-of-circulating-matrix-metalloproteinases-in-patients-suffering-from-heart-failure-in-relation-to-gen.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201606-0002_activities-of-circulating-matrix-metalloproteinases-in-patients-suffering-from-heart-failure-in-relation-to-gen.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2015/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2015/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201501-0001_influence-of-regulations-on-antihypertensives-utilization-in-slovakia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201501-0001_influence-of-regulations-on-antihypertensives-utilization-in-slovakia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201501-0002_speckle-tracking-echocardiography-and-diagnosis-of-subclinical-myocardial-dysfunction-past-present-future.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201501-0002_speckle-tracking-echocardiography-and-diagnosis-of-subclinical-myocardial-dysfunction-past-present-future.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201501-0003_varying-left-ventricular-outflow-obstruction-due-to-atriovantricular-dyssynchrony-in-a-patient-with-hypertrophi.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201501-0003_varying-left-ventricular-outflow-obstruction-due-to-atriovantricular-dyssynchrony-in-a-patient-with-hypertrophi.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2015/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2015/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201502-0003_differences-between-renin-angiotensin-aldosterone-system-inhibitors-according-to-their-impact-on-mortality-and.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201502-0003_differences-between-renin-angiotensin-aldosterone-system-inhibitors-according-to-their-impact-on-mortality-and.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201502-0005_2014-esc-guidelines-on-the-diagnosis-and-treatment-of-aortic-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201502-0005_2014-esc-guidelines-on-the-diagnosis-and-treatment-of-aortic-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201502-0002_the-role-of-melatonin-in-protecting-the-heart-against-malignant-arrhythmias.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201502-0002_the-role-of-melatonin-in-protecting-the-heart-against-malignant-arrhythmias.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201502-0001_comment-on-esc-guidelines-on-the-diagnosis-and-treatment-of-aortic-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201502-0001_comment-on-esc-guidelines-on-the-diagnosis-and-treatment-of-aortic-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201502-0004_comment-on-esc-guidelines-on-the-diagnosis-and-treatment-of-aortic-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201502-0004_comment-on-esc-guidelines-on-the-diagnosis-and-treatment-of-aortic-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2015/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2015/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201503-0002_the-nurse-and-nursing-in-ischemic-heart-disease-secondary-prevention.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201503-0002_the-nurse-and-nursing-in-ischemic-heart-disease-secondary-prevention.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201503-0003_thoracic-aortic-aneurysm-clinical-surgical-and-anesthetic-consideration.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201503-0003_thoracic-aortic-aneurysm-clinical-surgical-and-anesthetic-consideration.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201503-0004_what-is-a-structural-myocardial-remodeling.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201503-0004_what-is-a-structural-myocardial-remodeling.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201503-0005_2014-esc-guidelines-on-diagnosis-and-management-of-hypertrophic-cardiomyopathy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201503-0005_2014-esc-guidelines-on-diagnosis-and-management-of-hypertrophic-cardiomyopathy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201503-0001_functional-and-structural-pattern-of-conduit-arteries-in-two-models-of-experimental-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201503-0001_functional-and-structural-pattern-of-conduit-arteries-in-two-models-of-experimental-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201503-0006_comments-on-the-2014-esc-guidelines-on-the-diagnosis-and-management-of-hypertrophic-cardiomyopathy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201503-0006_comments-on-the-2014-esc-guidelines-on-the-diagnosis-and-management-of-hypertrophic-cardiomyopathy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2015/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2015/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201504-0004_pathological-changes-in-cardiovascular-system-in-long-term-doxorubicin-treated-rats-and-effect-of-quercetin.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201504-0004_pathological-changes-in-cardiovascular-system-in-long-term-doxorubicin-treated-rats-and-effect-of-quercetin.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201504-0005_the-effect-of-ppar-agonist-pioglitazone-on-hypertension-and-redox-regulation-in-young-and-adult-shr.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201504-0005_the-effect-of-ppar-agonist-pioglitazone-on-hypertension-and-redox-regulation-in-young-and-adult-shr.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201504-0006_ambulatory-blood-pressure-monitoring-in-relation-to-daily-routine-activities.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201504-0006_ambulatory-blood-pressure-monitoring-in-relation-to-daily-routine-activities.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201504-0007_ambulatory-blood-pressure-monitoring-indicator-of-blood-pressure-control.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201504-0007_ambulatory-blood-pressure-monitoring-indicator-of-blood-pressure-control.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201504-0001_role-of-sympathetic-nervous-system-in-the-pathophysiology-of-resistant-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201504-0001_role-of-sympathetic-nervous-system-in-the-pathophysiology-of-resistant-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201504-0002_strategy-of-combination-antihypertensive-therapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201504-0002_strategy-of-combination-antihypertensive-therapy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201504-0003_hyperuricaemia-and-clinical-relation-heart-kidney-and-blood-vessels.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201504-0003_hyperuricaemia-and-clinical-relation-heart-kidney-and-blood-vessels.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201504-0009_2014-esc-esa-guidelines-on-non-cardiac-surgery-cardiovascular-assessment-andmanagement.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201504-0009_2014-esc-esa-guidelines-on-non-cardiac-surgery-cardiovascular-assessment-andmanagement.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201504-0008_comment-on-2014-esc-esa-guidelines-on-non-cardiac-surgery-cardiovascular-assessment-and-management.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201504-0008_comment-on-2014-esc-esa-guidelines-on-non-cardiac-surgery-cardiovascular-assessment-and-management.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2015/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2015/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201505-0001_baroreflex-sensitivity-and-resistant-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201505-0001_baroreflex-sensitivity-and-resistant-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201505-0002_the-relationship-between-the-sleep-quality-and-blood-pressure-values-before-and-after-therapy-with-rilmenidine.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201505-0002_the-relationship-between-the-sleep-quality-and-blood-pressure-values-before-and-after-therapy-with-rilmenidine.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201505-0003_impact-of-blood-pressure-and-hydratation-using-bioimpedance-spectroscopy-on-left-ventricle-geometry-and-funct.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201505-0003_impact-of-blood-pressure-and-hydratation-using-bioimpedance-spectroscopy-on-left-ventricle-geometry-and-funct.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201505-0005_2014-esc-eacts-guidelines-on-myocardial-revascularization.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201505-0005_2014-esc-eacts-guidelines-on-myocardial-revascularization.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201505-0004_comment-on-2014-esc-eacts-guidelines-on-myocardial-revascularization.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201505-0004_comment-on-2014-esc-eacts-guidelines-on-myocardial-revascularization.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2015/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2015/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201506-0001_treatment-of-hypertension-in-pregnancy-a-3-year-retrospective-study.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201506-0001_treatment-of-hypertension-in-pregnancy-a-3-year-retrospective-study.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201506-0002_markers-of-endothelial-dysfunction-as-predictors-of-gestational-hypertension-and-preeclampsia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201506-0002_markers-of-endothelial-dysfunction-as-predictors-of-gestational-hypertension-and-preeclampsia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201506-0003_the-role-of-dexmedetomidine-in-the-prevention-of-postoperative-delirium-in-cardiac-surgery-patients.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201506-0003_the-role-of-dexmedetomidine-in-the-prevention-of-postoperative-delirium-in-cardiac-surgery-patients.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201506-0004_emerging-drugs-for-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201506-0004_emerging-drugs-for-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201506-0005_intolerance-of-statin-treatment.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201506-0005_intolerance-of-statin-treatment.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201506-0007_2014-esc-guidelines-on-the-diagnosis-and-management-of-acute-pulmonary-embolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201506-0007_2014-esc-guidelines-on-the-diagnosis-and-management-of-acute-pulmonary-embolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201506-0006_comment-on-2014-esc-guidelines-on-the-diagnosis-and-management-of-acute-pulmonary-embolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201506-0006_comment-on-2014-esc-guidelines-on-the-diagnosis-and-management-of-acute-pulmonary-embolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2014/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2014/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201401-0003_paraoxonase-1-and-its-effect-on-myocardial-graft-rejection-in-patients-after-heart-transplantation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201401-0003_paraoxonase-1-and-its-effect-on-myocardial-graft-rejection-in-patients-after-heart-transplantation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201401-0004_can-we-improve-cardiovascular-prognosis-by-further-intervention-of-serum-ldl-cholesterol-level.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201401-0004_can-we-improve-cardiovascular-prognosis-by-further-intervention-of-serum-ldl-cholesterol-level.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201401-0005_rarity-complication-of-pacemaker-implantation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201401-0005_rarity-complication-of-pacemaker-implantation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201401-0002_omega-3-polyunsaturated-fatty-acids-affect-arrhythmogenic-factors-and-attenuate-susceptibility-of-the-heart-to.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201401-0002_omega-3-polyunsaturated-fatty-acids-affect-arrhythmogenic-factors-and-attenuate-susceptibility-of-the-heart-to.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201401-0001_what-is-the-benefit-of-new-guidelines-for-the-diagnosis-and-therapy-of-hypertenzion-comment-on-2013-esh-esc-gu.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201401-0001_what-is-the-benefit-of-new-guidelines-for-the-diagnosis-and-therapy-of-hypertenzion-comment-on-2013-esh-esc-gu.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2014/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2014/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201402-0001_the-impact-of-atrial-fibrillation-ablation-on-symptoms-and-arrhythmia-burden-the-role-of-pre-and-post-ablation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201402-0001_the-impact-of-atrial-fibrillation-ablation-on-symptoms-and-arrhythmia-burden-the-role-of-pre-and-post-ablation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201402-0002_current-trends-in-management-of-nste-acs-patients-in-the-slovak-republic-analysis-of-the-slovaks-2-registry-fr.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201402-0002_current-trends-in-management-of-nste-acs-patients-in-the-slovak-republic-analysis-of-the-slovaks-2-registry-fr.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201402-0003_long-term-outcome-and-complications-after-catheter-closure-of-persistent-arterial-duct.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201402-0003_long-term-outcome-and-complications-after-catheter-closure-of-persistent-arterial-duct.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201402-0004_the-effect-of-neuronal-no-synthase-inhibition-on-the-cardiovascular-system-of-wistar-rats-from-the-prenatal-per.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201402-0004_the-effect-of-neuronal-no-synthase-inhibition-on-the-cardiovascular-system-of-wistar-rats-from-the-prenatal-per.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2014/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2014/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201403-0002_transcatheter-implantation-of-the-self-expandable-aortic-valve-bioprosthesis-in-a.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201403-0002_transcatheter-implantation-of-the-self-expandable-aortic-valve-bioprosthesis-in-a.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201403-0003_evaluation-of-carotid-artery-stiffness-and-flow-mediated-vasodilation-in-patients-with-resistant-hypertension-a.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201403-0003_evaluation-of-carotid-artery-stiffness-and-flow-mediated-vasodilation-in-patients-with-resistant-hypertension-a.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201403-0004_patent-foramen-ovale-transcatheter-closure-or-conservative-dive-profile-in-decompression-sickness-prevention-i.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201403-0004_patent-foramen-ovale-transcatheter-closure-or-conservative-dive-profile-in-decompression-sickness-prevention-i.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201403-0005_the-role-of-mitochondria-in-preconditioning-of-heart-induced-by-diazoxide-new-insight-into-the-molecular-mecha.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201403-0005_the-role-of-mitochondria-in-preconditioning-of-heart-induced-by-diazoxide-new-insight-into-the-molecular-mecha.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201403-0006_is-vasovagal-syncope-a-genetic-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201403-0006_is-vasovagal-syncope-a-genetic-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201403-0001_new-treatments-for-dyslipidemia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201403-0001_new-treatments-for-dyslipidemia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2014/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2014/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201404-0001_long-term-follow-up-of-aortic-stenosis-after-balloon-valvuloplasty-in-childhood-single-center-results.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201404-0001_long-term-follow-up-of-aortic-stenosis-after-balloon-valvuloplasty-in-childhood-single-center-results.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201404-0003_ischaemic-heart-disease-can-it-be-treated-by-influencing-cardiac-metabolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201404-0003_ischaemic-heart-disease-can-it-be-treated-by-influencing-cardiac-metabolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201404-0002_cardial-amyloidosis-in-the-context-of-new-pathophysiological-knowledge.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201404-0002_cardial-amyloidosis-in-the-context-of-new-pathophysiological-knowledge.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2014/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2014/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201405-0002_natriuretic-peptides-and-heart-failure-useful-in-early-diagnosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201405-0002_natriuretic-peptides-and-heart-failure-useful-in-early-diagnosis.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201405-0003_myocardial-neovascularization-in-the-janus-view.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201405-0003_myocardial-neovascularization-in-the-janus-view.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201405-0004_cryoballoon-ablation-valuable-enhancement-of-the-methods-of-paroxysmal-atrial-fibrillation-treatment.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201405-0004_cryoballoon-ablation-valuable-enhancement-of-the-methods-of-paroxysmal-atrial-fibrillation-treatment.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201405-0006_carcinoid-crisis-imitates-acute-pulmonary-embolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201405-0006_carcinoid-crisis-imitates-acute-pulmonary-embolism.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201405-0005_disorders-of-mitochondria-in-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201405-0005_disorders-of-mitochondria-in-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201405-0001_hypoxia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201405-0001_hypoxia.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2014/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2014/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201406-0001_the-effect-of-ivabradine-administration-on-heart-rate-blood-pressure-and-secretion-of-epinephrine-norepineph.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201406-0001_the-effect-of-ivabradine-administration-on-heart-rate-blood-pressure-and-secretion-of-epinephrine-norepineph.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201406-0002_the-effect-of-oxidative-stress-on-acetylcholine-induced-relaxation-in-deendothelized-arteries.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201406-0002_the-effect-of-oxidative-stress-on-acetylcholine-induced-relaxation-in-deendothelized-arteries.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201406-0003_troponins-and-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201406-0003_troponins-and-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2013/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2013/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201301-0001_effect-of-blood-pressure-on-carotid-stiffness-and-ventricular-arterial-coupling.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201301-0001_effect-of-blood-pressure-on-carotid-stiffness-and-ventricular-arterial-coupling.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201301-0002_renal-denervation-in-resistant-hypertension-revolution-in-therapy-or-blind-alley.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201301-0002_renal-denervation-in-resistant-hypertension-revolution-in-therapy-or-blind-alley.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2013/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2013/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201302-0003_long-term-effect-of-prazosin-and-losartan-administration-on-the-structure-and-function-of-the-cardiovascular-sy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201302-0003_long-term-effect-of-prazosin-and-losartan-administration-on-the-structure-and-function-of-the-cardiovascular-sy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201302-0002_current-trends-in-management-of-stemi-in-the-slovak-republic-the-analysis-of-the-slovaks-2-registry-from-2011.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201302-0002_current-trends-in-management-of-stemi-in-the-slovak-republic-the-analysis-of-the-slovaks-2-registry-from-2011.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201302-0001_carotid-artery-stenting-in-octogenarians-in-high-volume-centre.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201302-0001_carotid-artery-stenting-in-octogenarians-in-high-volume-centre.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2013/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2013/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201303-0005_hypertension-in-pregnancy-and-increased-cardiovascular-risk-the-importance-for-clinical-practice-of-the-asses.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201303-0005_hypertension-in-pregnancy-and-increased-cardiovascular-risk-the-importance-for-clinical-practice-of-the-asses.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201303-0002_significance-of-baroreflex-sensitivity-in-advanced-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201303-0002_significance-of-baroreflex-sensitivity-in-advanced-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201303-0001_measurement-of-the-anticoagulant-activity-and-reversal-of-anticoagulant-effect-of-the-novel-oral-anticoagulants.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201303-0001_measurement-of-the-anticoagulant-activity-and-reversal-of-anticoagulant-effect-of-the-novel-oral-anticoagulants.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201303-0003_torsade-de-pointes-caused-by-salmonella-typhi-infection.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201303-0003_torsade-de-pointes-caused-by-salmonella-typhi-infection.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201303-0004_increased-resistance-of-diabetic-mitochondria-to-ischemia-reperfusion-myocardial-injury.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201303-0004_increased-resistance-of-diabetic-mitochondria-to-ischemia-reperfusion-myocardial-injury.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2013/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2013/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201304-0001_impact-of-left-ventricular-systolic-dysfunction-on-the-right-ventricle-in-terms-of-three-dimensional-echocardio.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201304-0001_impact-of-left-ventricular-systolic-dysfunction-on-the-right-ventricle-in-terms-of-three-dimensional-echocardio.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201304-0002_reevaluation-of-the-electrocardiographic-pattern-of-left-bundle-branch-block-for-proper-patient-selection-and-b.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201304-0002_reevaluation-of-the-electrocardiographic-pattern-of-left-bundle-branch-block-for-proper-patient-selection-and-b.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201304-0003_dilemmas-of-diagnosis-and-treatment-of-hypertension-in-pregnancy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201304-0003_dilemmas-of-diagnosis-and-treatment-of-hypertension-in-pregnancy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2013/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2013/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201305-0003_combination-of-ace-inhibitor-perindopril-arginine-and-calcium-channel-blocker-amlodipine-more-than-only-a-redu.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201305-0003_combination-of-ace-inhibitor-perindopril-arginine-and-calcium-channel-blocker-amlodipine-more-than-only-a-redu.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201305-0004_anaemia-and-heart-failure-how-to-treat-this-patient.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201305-0004_anaemia-and-heart-failure-how-to-treat-this-patient.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201305-0001_pocket-size-echocardiography.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201305-0001_pocket-size-echocardiography.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201305-0002_thyroid-and-cardiovascular-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201305-0002_thyroid-and-cardiovascular-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2013/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2013/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201306-0001_echocardiography-and-mr-evaluation-of-aortic-coarctation-and-recoarctation-influence-of-aortic-arch-deformity.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201306-0001_echocardiography-and-mr-evaluation-of-aortic-coarctation-and-recoarctation-influence-of-aortic-arch-deformity.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201306-0002_the-causes-of-changes-in-coronary-heart-disease-mortality-rates-using-the-impact-model-a-systematic-review.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201306-0002_the-causes-of-changes-in-coronary-heart-disease-mortality-rates-using-the-impact-model-a-systematic-review.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201306-0003_pulmonary-artery-systolic-pressure-direct-measurement-versus-echocardiograhic-estimation-in-patients-with-pul.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201306-0003_pulmonary-artery-systolic-pressure-direct-measurement-versus-echocardiograhic-estimation-in-patients-with-pul.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2012/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2012/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201201-0002_microvascular-angina-pectoris-cardiac-syndrome-x-and-its-relation-to-insulin-resistance-and-metabolic-syndrom.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201201-0002_microvascular-angina-pectoris-cardiac-syndrome-x-and-its-relation-to-insulin-resistance-and-metabolic-syndrom.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201201-0001_hyponatremia-available-and-reliable-risk-predictor-in-acute-heart-failure-patients.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201201-0001_hyponatremia-available-and-reliable-risk-predictor-in-acute-heart-failure-patients.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2012/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2012/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201202-0001_thromboembolic-risk-profile-in-patients-with-atrial-fibrillation-in-internal-and-cardiologic-outpatient-clinics.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201202-0001_thromboembolic-risk-profile-in-patients-with-atrial-fibrillation-in-internal-and-cardiologic-outpatient-clinics.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201202-0002_quality-of-oral-anticoagulation-therapy-with-warfarin-in-the-outpatient-clinical-practice-in-slovakia-in-patien.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201202-0002_quality-of-oral-anticoagulation-therapy-with-warfarin-in-the-outpatient-clinical-practice-in-slovakia-in-patien.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201202-0003_the-application-of-fluorescence-analysis-in-early-acute-corovary-syndrome-diagnostics.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201202-0003_the-application-of-fluorescence-analysis-in-early-acute-corovary-syndrome-diagnostics.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2012/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2012/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201203-0001_contemporary-treatment-of-pulmonary-arterial-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201203-0001_contemporary-treatment-of-pulmonary-arterial-hypertension.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201203-0002_risk-related-to-low-cholesterol-levels.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201203-0002_risk-related-to-low-cholesterol-levels.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201203-0003_first-use-of-impella-2-5-supportive-circulatory-system-within-patient-with-acute-stemi-in-cardiogenic-shock-tr.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201203-0003_first-use-of-impella-2-5-supportive-circulatory-system-within-patient-with-acute-stemi-in-cardiogenic-shock-tr.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201203-0004_recurrent-pericarditis-as-the-first-clinic-sign-of-systemic-lupus-erythematosus.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201203-0004_recurrent-pericarditis-as-the-first-clinic-sign-of-systemic-lupus-erythematosus.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2012/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2012/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201204-0001_influence-of-age-blood-pressure-body-mass-index-laboratory-parameters-and-left-ventricular-ejection-fraction.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201204-0001_influence-of-age-blood-pressure-body-mass-index-laboratory-parameters-and-left-ventricular-ejection-fraction.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201204-0002_long-term-prognosis-of-patients-after-acute-myocardial-infarction-in-2006-2007-from-the-bratislava-v-district.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201204-0002_long-term-prognosis-of-patients-after-acute-myocardial-infarction-in-2006-2007-from-the-bratislava-v-district.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201204-0003_new-directions-in-guidelines-on-hypertension-treatment-are-fixed-dosed-combinations-of-antihypertensive-drugs.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201204-0003_new-directions-in-guidelines-on-hypertension-treatment-are-fixed-dosed-combinations-of-antihypertensive-drugs.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201204-0004_is-correct-diagnose-always-correct-ct-finding-of-papvd-at-patient-after-surgical-correction-of-papvd.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201204-0004_is-correct-diagnose-always-correct-ct-finding-of-papvd-at-patient-after-surgical-correction-of-papvd.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2012/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2012/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201205-0003_may-growth-hormone-and-igf-1-concentrations-be-used-in-the-stratification-of-additional-cardiovascular-risk-in.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201205-0003_may-growth-hormone-and-igf-1-concentrations-be-used-in-the-stratification-of-additional-cardiovascular-risk-in.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201205-0006_pharmacotherapy-aimed-at-reducing-ldl-cholesterol-statins-combined-hypolipidemic-therapy-and-what-next.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201205-0006_pharmacotherapy-aimed-at-reducing-ldl-cholesterol-statins-combined-hypolipidemic-therapy-and-what-next.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201205-0007_circadian-rhythmicity-of-the-cardiovascular-system.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201205-0007_circadian-rhythmicity-of-the-cardiovascular-system.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201205-0008_the-role-of-three-dimensional-echocardiography-in-the-diagnosis-of-chronic-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201205-0008_the-role-of-three-dimensional-echocardiography-in-the-diagnosis-of-chronic-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201205-0004_treatment-of-stentgraft-infection-with-fresh-frozen-arterial-allograft-following-endovascular-aortic-repair-fo.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201205-0004_treatment-of-stentgraft-infection-with-fresh-frozen-arterial-allograft-following-endovascular-aortic-repair-fo.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201205-0005_first-case-of-erosion-after-an-atrial-septal-defect-closure-with-the-amplatzer-septal-occluder-at-the-children.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201205-0005_first-case-of-erosion-after-an-atrial-septal-defect-closure-with-the-amplatzer-septal-occluder-at-the-children.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201205-0002_salutary-effects-of-red-palm-oil-intake-on-post-ischemic-heart-recovery-and-incidence-of-malignant-arrhythmias.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201205-0002_salutary-effects-of-red-palm-oil-intake-on-post-ischemic-heart-recovery-and-incidence-of-malignant-arrhythmias.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201205-0001_fabry-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201205-0001_fabry-disease.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2012/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2012/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201206-0005_catheter-ablation-of-atrial-fibrillation-where-have-we-come-from-where-are-we-today-and-where-are-we-heading.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201206-0005_catheter-ablation-of-atrial-fibrillation-where-have-we-come-from-where-are-we-today-and-where-are-we-heading.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201206-0001_rosuvastatin-has-therapeutic-potential-in-patients-after-heart-transplantation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201206-0001_rosuvastatin-has-therapeutic-potential-in-patients-after-heart-transplantation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201206-0002_characteristics-and-long-term-survival-in-patients-with-advanced-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201206-0002_characteristics-and-long-term-survival-in-patients-with-advanced-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201206-0003_do-we-know-the-situation-of-the-patients-hospitalized-for-acute-heart-failure-with-preserved-ejection-fraction.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201206-0003_do-we-know-the-situation-of-the-patients-hospitalized-for-acute-heart-failure-with-preserved-ejection-fraction.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201206-0006_corrected-transposition-of-the-great-arteries-in-senior-with-dextrocardia-and-chronic-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201206-0006_corrected-transposition-of-the-great-arteries-in-senior-with-dextrocardia-and-chronic-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201206-0004_diabetes-and-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201206-0004_diabetes-and-heart-failure.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2011/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2011/mn1.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201101-0001_the-role-of-calcium-calmodulin-dependent-protein-kinase-ii-camkii-in-the-protection-of-the-heart-against-fata.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201101-0001_the-role-of-calcium-calmodulin-dependent-protein-kinase-ii-camkii-in-the-protection-of-the-heart-against-fata.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201101-0002_manual-thrombus-aspiration-in-management-of-myocardial-infarction-with-st-segment-elevation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201101-0002_manual-thrombus-aspiration-in-management-of-myocardial-infarction-with-st-segment-elevation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2011/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2011/mn2.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201102-0001_opposite-effect-of-endothelial-and-neuronal-no-synthase-inhibition-on-the-cardiovascular-system-in-experiment.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201102-0001_opposite-effect-of-endothelial-and-neuronal-no-synthase-inhibition-on-the-cardiovascular-system-in-experiment.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201102-0002_distal-aortic-dissection-in-infrarenal-area.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201102-0002_distal-aortic-dissection-in-infrarenal-area.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201102-0003_imminent-paradoxical-embolisation-during-an-echocardiographical-examination.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201102-0003_imminent-paradoxical-embolisation-during-an-echocardiographical-examination.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2011/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2011/mn3.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201103-0003_acetylsalicylic-acid-where-is-its-real-place-in-the-therapy-of-patients-with-diabetes-mellitus.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201103-0003_acetylsalicylic-acid-where-is-its-real-place-in-the-therapy-of-patients-with-diabetes-mellitus.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201103-0004_clinical-synergy-of-perindopril-arginine-and-amlodipine-combination-in-hypertension-thera.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201103-0004_clinical-synergy-of-perindopril-arginine-and-amlodipine-combination-in-hypertension-thera.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201103-0005_importance-of-serotonin-in-the-etiopathogenesis-of-iatrogenic-valvular-heart-diseases-and-pulmonary-hypertensio.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201103-0005_importance-of-serotonin-in-the-etiopathogenesis-of-iatrogenic-valvular-heart-diseases-and-pulmonary-hypertensio.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201103-0001_overestimated-effect-of-body-height-on-blood-pressure-in-national-blood-pressure-education-program-nhbpep-cla.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201103-0001_overestimated-effect-of-body-height-on-blood-pressure-in-national-blood-pressure-education-program-nhbpep-cla.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201103-0002_nkle-brachial-index-as-a-predictor-of-cardiovascular-morbidity-and-mortality.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201103-0002_nkle-brachial-index-as-a-predictor-of-cardiovascular-morbidity-and-mortality.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2011/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2011/mn4.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201104-0001_gender-differences-and-early-mortality-in-acute-myocardial-infarction.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201104-0001_gender-differences-and-early-mortality-in-acute-myocardial-infarction.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201104-0002_alterations-of-myocardial-nos-activity-and-connexin-43-expression-in-rats-suffering-from-hypertension-and-hyper.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201104-0002_alterations-of-myocardial-nos-activity-and-connexin-43-expression-in-rats-suffering-from-hypertension-and-hyper.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201104-0003_copeptin-as-novel-and-significant-marker-in-the-diagnostics-and-prognosis-of-acute-cardiovascular-diseases-and.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201104-0003_copeptin-as-novel-and-significant-marker-in-the-diagnostics-and-prognosis-of-acute-cardiovascular-diseases-and.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2011/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2011/mn5.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201105-0001_subcellular-characterization-of-coronary-arteries-and-aorta-of-patients-with-dilated-cardiomyopathy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201105-0001_subcellular-characterization-of-coronary-arteries-and-aorta-of-patients-with-dilated-cardiomyopathy.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201105-0002_carotid-stiffness-in-hypertensives.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201105-0002_carotid-stiffness-in-hypertensives.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201105-0003_coronary-risk-and-multidetector-computed-tomography-in-nondiabetic-patients-with-mild-renal-insufficiency.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201105-0003_coronary-risk-and-multidetector-computed-tomography-in-nondiabetic-patients-with-mild-renal-insufficiency.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201105-0004_cardioversion-related-changes-of-nt-probnp-levels-in-patients-with-atrial-fibrillation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201105-0004_cardioversion-related-changes-of-nt-probnp-levels-in-patients-with-atrial-fibrillation.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201105-0005_characteristics-of-hypertensive-patients-with-heart-failure-in-the-stairs-study.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201105-0005_characteristics-of-hypertensive-patients-with-heart-failure-in-the-stairs-study.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201105-0006_diagnosis-and-treatment-of-hypertension-in-children-and-adolescents.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201105-0006_diagnosis-and-treatment-of-hypertension-in-children-and-adolescents.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201105-0007_is-plasma-renin-activity-an-independet-risk-factor-of-cardiovascular-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201105-0007_is-plasma-renin-activity-an-independet-risk-factor-of-cardiovascular-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/magno/cal/2011/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
			<url>
			<loc>/en/magno/cal/2011/mn6.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201106-0001_analysis-of-cardiac-resynchronization-therapy-in-end-stage-heart-failure-patients.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201106-0001_analysis-of-cardiac-resynchronization-therapy-in-end-stage-heart-failure-patients.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201106-0002_methods-for-measurement-of-ldl-cholesterol-a-critical-assessment-of-direct-measurement-versus-calculation-in-t.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201106-0002_methods-for-measurement-of-ldl-cholesterol-a-critical-assessment-of-direct-measurement-versus-calculation-in-t.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201106-0003_prevalence-of-abnormal-glucose-regulation-and-its-optimal-screening-in-patients-with-acute-stemi.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201106-0003_prevalence-of-abnormal-glucose-regulation-and-its-optimal-screening-in-patients-with-acute-stemi.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201106-0004_association-between-fasting-glucose-level-and-ankle-brachial-index-in-patients-with-diabetes-mellitus-type-2-wi.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201106-0004_association-between-fasting-glucose-level-and-ankle-brachial-index-in-patients-with-diabetes-mellitus-type-2-wi.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201106-0005_the-occurrence-of-phenomena-of-metabolic-syndromes-in-500-patients-indicated-for-coronarography.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201106-0005_the-occurrence-of-phenomena-of-metabolic-syndromes-in-500-patients-indicated-for-coronarography.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/artkey/cal-201106-0006_cardiac-biomarkers-in-patients-with-chronic-kidney-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
		<url>
			<loc>/en/artkey/cal-201106-0006_cardiac-biomarkers-in-patients-with-chronic-kidney-diseases.php</loc>
			<changefreq>weekly</changefreq>
			<priority>0.7</priority>
		</url>
</urlset>
